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1.1 Scope and Aims
Functional data arise frequently in many fields of biomedical research as sequen-
tial observations over time. The observations are generated by an unknown dynamic
mechanism. This dynamic process has unspecified mean function, and the observa-
tions can be considered as arising from this mean function plus noise. The goal is
typically estimation and inference for the unknown mean function and its derivatives
as well as other parameters involved in the underlying dynamic system. Methods
from nonparametric and semiparametric regression are typically used to achieve this
goal.
1.1.1 Smoothing methods
Two widely used methods to estimate the unknown mean function are kernel
smoothing (Wand and Jones, 1995; Fan and Gijbels, 1996) and spline smoothing
(Wahba, 1990; Green and Silverman, 1994; Ramsay and Silverman, 2005). Suppose
we have observations Y (tj) at design points tj, j = 1, 2, . . . , J . The observations are
assumed to follow the model
Y (tj) = U(tj) + ε(tj), ε(tj)
i.i.d∼ N (0, σ2ε). (1.1)
1





where Wj,h(t) is the weight function centered at t with bandwidth h. A popular choice
of weight function is to use a kernel Kh(·), and the Wj,h(t) is given by
Wj,h(t) =
Kh(tj − t)∑J
j=1 Kh(tj − t)
.
This is called the Nadaraya−Watson local average kernel smoothing. Very often the
kernel function Kh(·) is chosen to be a density function with mean zero.





[Y (tj)− U(tj)]2 + λ
∫
L(U)2(t)dt,
where L is linear differential operator and λ is the smoothing parameter. The first
term of Sλ(U) measures the goodness-of-fit of U(·) to the data, while the second term
penalizes the roughness of U(·). The smoothing spline estimator of U(·) is obtained by
minimizing Sλ(U), where λ is determined typically through cross-validation. When
L(U) = D2(U) = U ′′, the minimizer corresponds to a natural cubic smoothing spline,
which is in fact a piecewise cubic polynomial.
The above two smoothing methods essentially regard the mean function U(t) as
a deterministic function and mainly focus on estimation of U(t). In this dissertation,
we take a different perspective , and treat U(t) as the realization or sample path of a
stochastic process. This will enable us to study dynamics of the underlying process,
including how the stochastic process and its derivatives evolve over time, both within
the observation time(through estimation and inference) and also afterwards(through
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forecasting).
1.1.2 Stochastic dynamic model
A stochastic dynamic model(SDM) refers to a class of hierarchical models, where
observations are sampled from distributions, which depend on an function determined
by some diffusion processes that evolve continuously and stochastically over time. The
SDM consists of two hierarchies: A d-dimensional discrete-time observation process
{Y t}t∈To with To := {tj : t1 < t2 < · · · < tJ} and m-dimensional continuous-time
latent state process {θt}t∈Ts with Ts := {t : t0 ≤ t ≤ tJ}, detailed as follows:
Po : The observation process {Y t}t∈To defined on state space (Rd,B(Rd)) gives
a collection of observations; given latent process θt, Y t is conditionally inde-
pendent of {Y s}s6=t and {θs}s6=t with the conditional distribution
Y t | θt ∼ ft(y | θt, Xo,φo),Y t ∈ Rd (1.2)
where Xo and φo are respectively the covariates and the parameter vector
involved.
Ps : The state process {θt}t∈Ts defined on state space (Rm,B(Rm)) is a latent
diffusion process, which is a Markov process with almost surely continuous
sample paths, governed by a stochastic differential equation(SDE),





θ1(t), · · · , θm(t)
]T
,
a{θ(t); Xs, φs, t} =
[
a1{θ(t); Xs,φs, t}, · · · , am{θ(t); Xs, φs, t}
]T
,
b{θ(t); Xs, φs, t} =


b11{θ(t); Xs,φs, t} . . . b1n{θ(t); Xs,φs, t}
...
...




is a n-dimensional independent Wiener process W (t) = [W1(t), · · · ,Wn(t)]T , Xs and
φs are the covariates and parameter vector involved. The elements of θ(t) usually
include a process U(t) and its first to qth order derivatives besides other covariate
processes. The vector of drift terms a{θ(t); Xs,φs, t} and the matrix of diffusion
terms b{θ(t); Xs,φs, t} are assumed to satisfy regularity conditions; see Grimmett
and Stirzaker (2001, Chap. 13) and Feller (1970, Chap. 10).
The SDM can be regarded as the generalization of the continuous-discrete state
space model (Jazwinski, 1970, Chap. 6) by allowing continuous and discrete observa-
tions as well as by including possible covariates. SDM has some similarity to other
modeling approaches, such as state space models (Jones, 1993; Durbin and Koopman,
2001), linear dynamic models (West and Harrison, 1997) and many other diffusion
type models in finance, e.g. the stochastic volatility model (Hull and White, 1987),
but are not identical to them. In the linear dynamic models, both the observations
and states exist at discrete time and the states are specified by conditional densi-
ties. The diffusion type models in finance have both continuous time observation and
states, and the states are usually directly or partially observed.
Estimation and inference for {θt}t∈Ts , φs and φo in SDM is very challenging, due
to the lack of closed form expression for the likelihood function, which involves high-
dimensional integrals, and to the requirement of inferring continuous unknown func-
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tions. To overcome those challenges, we develop Markov Chain Monte Carlo(MCMC)
based Bayesian inference utilizing the Euler approximation and data augmentation.
The estimation methods are described in chapter II.
The advantages of SDM as a modeling approach for functional data analysis in-
clude: i) SDM treats the unknown function as a realization of a stochastic diffu-
sion processes, governed by stochastic differential equations. In this way, we can
investigate not only the mean function nonparametrically but also its dynamics(or
derivatives), that may be of great interest in many applications; ii) Because it is a
fully specified probability model, inference and forecasting can be achieved using an
MCMC approach. In contrast, smoothing techniques are essentially point estimation
methods; iii) SDM is able to model not only smooth functions, but also non-smooth
functions, such as those with structural changes or breakpoints; iv), Covariates can
be incorporated into both the distribution of the observations, and the drift and dif-
fusion terms of the SDE in equation (1.3). Thus, covariate effects can be assessed in
the observation and/or state processes simultaneously.
In this dissertation, we mainly focus on the situation when the observations
{Y t}t∈To are continuous and explore various specific forms of SDEs in (1.3) for dif-
ferent purposes.
1.2 Organization of Dissertation
1.2.1 Organization
Chapter II introduces a new modeling strategy for time series functional data.
We consider the problem of estimating an unknown smooth function. The model
consists of an observation equation for the observation process, an ordinary differen-
tial equation(ODE) and a stochastic differential equation(SDE) for the state process.
The method of smoothing spline, introduced in section 1.1.1, is connected to a spe-
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cial case of this approach. The resulting models offer great flexibility to capture the
dynamic features of functional data, and allows straightforward and meaningful in-
terpretation. The likelihood of the models is derived with Euler approximation and
data augmentation. A unified Bayesian inference method for those models is carried
out via a MCMC algorithm with simulation smoother. The proposed models and
methods are illustrated on some prostate specific antigen(PSA) data, where we use
an Ornstein-Uhlenbeck process to model the rate of changes of PSA and achieve more
precise forecasting.
Chapter III presents a novel semiparametric stochastic approach to model the
rate functions for functional data in a multi-subject setting. The rate functions,
one for each subject, characterize the rate of change of individual profiles, and are
assumed to follow covariate-dependent Gaussian processes, which obey stochastic
differential equations. Consequently, each rate function is expected to be centered on
a parametric function, which may be dependent on the covariates, and nonparametric
departure is allowed from the parametric functional expectation. The profiles for
different subjects are linked to each other, because some parameters in the SDE are
common whereas others are unique and assumed to arise from a mixing distribution.
The proposed approach is flexible to capture the patterns of subject-specific rate of
change, convenient to study the covariate effects on the rate function, and easy for
interpretation of the results. The proposed methods are illustrated by analyzing a
prostate-specific antigen dataset with many subjects and through simulation studies.
Chapter IV proposes a time-varying stochastic position model with an observation
equation and an SDE, where the diffusion term is time-varying. In this way, the model
can approximate the breakpoints in a function. The discretized version of this model
assumes a t-distribution for both the measurement errors and the signal differences.
The discretized model is applied to array comparative genomic hybridization(CGH)
data analysis. The CGH profiles are regarded as functional unknown signals estimated
6
by a MCMC algorithm. Both breakpoints and outliers are identified by a backward
selection procedure. Glioblastoma Multiforme(GBM) data are used to demonstrate
the characteristics of the proposed method. Compared to three other popular meth-
ods, our approach has superior detection ability, which is illustrated on a simulated
dataset and a breast tumor dataset.




Stochastic Functional Data Analysis:
A Diffusion Model-based Approach
2.1 Introduction
Conventional nonparametric regression theory concerns primarily the estimation
of a population mean function through kernel smoothing (Fan and Gijbels, 1996)
and spline smoothing techniques (Green and Silverman, 1994). In many practical
settings, not only the mean function but also its derivatives (in general referred to
as dynamics) offer useful insights regarding the underlying mechanism of a physi-
cal or biological process. With the advent of many high-throughput technologies,
functional data analysis has received much attention in the recent statistical liter-
ature(Ramsay and Silverman, 2005), where tremendous challenges have emerged in
statistical methodology development.
This paper presents a new modeling strategy in functional data analysis. Our pri-
mary focus in modeling lies on a system of stochastic differential equations connected
in a hierarchical fashion, in the hope that it not only models the mechanism of the
population mean function but also captures various features of the dynamics of the
mean function. Consequently, we can make statistical inference on both means and
dynamics of the underlying process.
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For example, in the study of prostate specific antigen (PSA), an important biomarker
of prostate cancer, we are not only interested in the PSA level but also the dy-
namics of PSA. Figure 2.1 displays raw data of one patient’s PSA level (panel (a))
and the scaled difference (panel (b)) over time (Proust-Lima et al., 2008b), where
Y (t) = log(PSA(t) + 0.1) and scaled difference is ∆Y
∆t
. It is easy to observe that the
PSA level is largely driven by the behavior of the scaled difference that itself provides
meaningful clinical interpretation. Hence, modeling the process of the scaled differ-
ence properly will facilitate the modeling of the PSA level. However, the connection
between the PSA level and the scale difference cannot be established simply by as-
sociation, but instead by hierarchical models of dynamics, as the scaled difference
may be regarded as the first order derivative of the PSA level. While panel (a) and
panel (b) show the data, by using the model(to be described in section 4.1), we can
make probability statements about features of the curves. For example, in Figure 2.1
panel (c) we show the posterior probability of the time when PSA level reaches its
minimum.
Consider a regression model for functional data of the form:
Y (t) = U(t, ω) + ε(t), ω ∈ Ω, t ∈ To (2.1)
where Ω is the sample space, To is the index set of observation times, defined as
To := {tj : t1 < t2 < · · · < tJ}, and U(· , ω) is an unknown function of interest to be
estimated and ε(t) ∼ N (0, σ2ε) at each time t. The goal is to estimate the function
U(· , ω) given time series observations, Y o = [Y (t1), Y (t2), . . . , Y (tJ)]T. In this paper,
we develop methods based on diffusion type models for estimation of U(· , ω) and its
derivatives U (p)(· , ω), p = 1, . . . ,m − 1. Here, U(· , ω) is regarded as a sample path
realization of an underlying stochastic process U := U(· , · ) and the observed data is
thus process plus measurement error.
Model (2.1) is useful to model the PSA level of prostate cancer nonparametrically,
9

































































Figure 2.1: PSA plots: (a) the raw data; (b) the scaled difference; (c) posterior prob-
ability of minimum of PSA level at interval [tj, tj+1] in SVM-OU
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where U(t, ω) describes the population mean PSA process. In addition, to understand
the dynamics profiles concerning the evolution of the biomarker process, we incorpo-
rate models of rate(or velocity) and/or higher order derivatives into model (2.1). To
proceed, we begin by treating U(t, ω) in model (2.1) as a realization of U(t) := U(t, · ),
which enables us to express U(t) in the form of a stochastic diffusion model. That is,
the stochastic process U satisfies the following ordinary differential equation(ODE),
dm−1U(t)
dtm−1
= V (t), (2.2)
and its (m− 1)th order derivative V (t) is governed by a stochastic differential equa-
tion(SDE), given as follows:
dV (t) = a{V (t),φs}dt + b{V (t),φs}dW (t), t ∈ Ts, (2.3)
where W (t) is the standard Wiener process, φs is the parameter vector and Ts :=
{t : t0 ≤ t ≤ tJ} is a continuous index set. In addition, the initial condition at time
t0 is assumed to be θ(t0) := [U(t0), U
(1)(t0), . . . , U
(m−2)(t0), V (t0)]T ∼ Nm(0, σ20Im).
In this paper, we use continuous time stochastic processes U and V to model the
underlying dynamics of interest. Let V := {V (t, ω) : t ∈ Ts, ω ∈ Ω}, defined on a
probability space (Ω,F ,P). We limit V to a one-dimensional continuous state space
and a continuous index set Ts. Similar definition and limitation hold for U . The
SDE in (2.3) defines a stochastic diffusion process V , which is a Markov process with
almost surely continuous sample paths. The existence and uniqueness of the process
can be shown rigorously; see Grimmett and Stirzaker (2001, Chap. 13) and Feller
(1970, Chap. 10).
The state equations (2.2) and (2.3), along with the observation equation (2.1),
make up a continuous-discrete state space model (CDSSM) (Jazwinski, 1970, Chap. 6).
Although inference methods will be demonstrated for the stochastic velocity model(SVM),
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namely the CDSSM with m = 2, they are applicable to any higher order of m. For
example, m = 3 corresponding to a stochastic acceleration model(SAM). For SVM,
the latent process U(t) represents position, and its first derivative V (t) is the velocity
of U(t). Similarly, in the SAM, the processes θ(t) := [U(t), U (1)(t), V (t)]T repre-
sent the position, velocity and acceleration respectively. Coefficients a{V (t),φs} and
b{V (t), φs} in (2.3) are typically specified according to the objectives of a given study.
The drift term a{V (t),φs} can be interpreted as the instantaneous mean of velocity;
it represents the expected conditional acceleration when V (t) denotes velocity. Like-
wise, b2{V (t),φs} measures the instantaneous variance or volatility of velocity. Two
special cases are considered in this paper. They are, (i) SVM and SAM with Wiener
process V (t), denoted SVM-W and SAM-W, where a{V (t),φs} = 0, b{V (t),φs} = σξ
and φs = σ
2
ξ ; (ii) SVM and SAM with Ornstein-Uhlenbeck(OU) process V (t), denoted
SVM-OU and SAM-OU, where a{V (t),φs} = −ρ{V (t) − ν̄}, b{V (t),φs} = σξ and
φs = [ρ, ν̄, σ
2
ξ ]
T. These two processes will be discussed in detail in Section 2.
When V (t) follows a Wiener process, as shown in the literature, there exists
an interesting “equivalence” between smoothing splines and Bayesian estimation of
SVM-W(Kimeldorf and Wahba, 1970; Wahba, 1978; Weinert and Sidhu, 1980). By
equivalence, we mean that the two methods give the same estimate of U(t). To
elaborate, let Û(t; σ20) := E{U(t) | Y o; σε, σξ, σ20} be the posterior mean of U(t) in
SVM-W . Wahba (1978) showed that Û(t) := lim
σ20→∞
Û(t; σ20) exists and is the same
as the estimate obtained by the smoothing spline with degree 2m − 1 and 2m − 2




[y(tj)− U(tj)]2 + λPm(U), (2.4)
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[U (m)(t, ω)]2dt, m = 2, 3, . . . , (2.5)
Kimeldorf and Wahba (1970) and Wahba (1978) have shown the “equivalence” by
treating penalized sum-of-squares (2.4) as the minimal norm optimization problem
in a Reproducing Kernel Hilbert Space, where the kernel is regarded as the variance
covariance function of the stochastic process U in SVM-W ; see also Ansley and Kohn
(1986) for a detailed discussion. In short, the posterior mean of U(t) in SVM-W can
be equivalently obtained by the smoothing spline. Diggle and Hutchinson (1989) and
Kohn and Ansley (1988) found that the equivalence results can hold for more general
covariance matrices than the diagonal matrix of independent measurement errors ε(t).
For the PSA data example in figure 2.1 it is obvious that the scaled difference
is varying around a certain level after about 3 years, which is more consistent with
the behavior of an OU process than a Wiener process, suggesting that the SVM-OU
may fit better. In other applications, the data may demonstrate different patterns,
for example, periodic patterns, which require more flexible models to address those
complicated dynamic features. The diffusion model and the consideration of higher
derivative in (2.2) allow considerable flexibility and the incorporation of various dy-
namic features into the two coefficients a{V (t),φs} ∈ R and b{V (t),φs} ∈ R+. By
this model-based approach, various stochastic processes can be specified for V (t), the
model fitting can be evaluated by likelihood-based model assessment, and forecasting
can also be easily carried out, which is very useful in biomedical and other research.
Note that in this paper we treat the function U(t, ω) in model (2.1) as a sample
path of the stochastic process U . This treatment is different from kernel smoothing
and spline smoothing, where U(t, ω) is regarded as a deterministic unknown func-
tion. We also note that our treatment of U(t, ω) is similar to that considered in
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the Gaussian process models for nonparametric Bayesian data analysis, where the
nonparametric function U(t, ω) is governed by a prior Gaussian process with a mean
function M(t; φ) and a covariance function C(t, t′; φ) with hyperparameters φ (Muller
and Quintana, 2004; Rasmussen and Williams, 2006). In term of statistical estima-
tion and inference, our method offers the estimation and inference for parameters of
the stochastic differential equation from noisy data. We note that this differs from
the approaches to parameters estimation for models based on ordinary differential
equations as recently developed by, for example, Ramsay et al. (2007) and Liang and
Wu (2008).
The rest of the paper is organized as follows. Section 2.2 concerns two special
cases of the proposed stochastic velocity model, one with the Wiener process V (t)
and the other with the OU process V (t). For each cases, we give model interpretations
and discuss several interesting relationships. Section 2.3 develops Bayesian inference
for stochastic functional data analysis models, illustrated by the SVM, where the
likelihood is derived using Euler approximation and data augmentation. In Section
2.4, the proposed models and methods are applied to estimate the PSA profile from
prostate cancer data. Concluding remarks are given in Section 2.5. Technical details
are included in the Appendix.
2.2 Examples of stochastic velocity model
We focus on two SVMs, where velocities are modelled by specific forms for the
SDE. The first is the SVM-W, for which we will point out its connections to the
problem of model adequacy. The second is the SVM-OU, in which we examine its
relationship to the Wiener process and AR(1) model. For both special cases, we also
give the interpretation of the parameters φs. Similar interpretations can be applied
to the SAM, substituting the acceleration for the velocity.
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2.2.1 Wiener process for velocity
In SVM-W, V (t) follows the Wiener process, the instantaneous variance σ2ξ mea-
sures the disturbance of velocity and influences the smoothness of U(t). With the
smaller the σ2ξ , V (t) will appear less wiggly and hence U(t) will be smoother. If
σξ = 0, the velocity V (t) is constant over time, so U(t) becomes a straight line.
Integrating (2.2) and (2.3) for m = 2, a{V (t),φs} = 0 and b{V (t), φs} = σξ, we
have
U(t) = U(t0) +
t∫
t0
V (s) ds = U(t0) + V (t0)(t− t0) + σξ
t∫
t0
W (s) ds, (2.6)
V (t) = V (t0) + σξW (t). (2.7)
The velocity V (t) follows the Wiener process starting at V (t0). The position U(t)





2.2.2 Ornstein-Uhlenbeck process for velocity
The OU process originated as a model for the velocity of a particle suspended in
fluid (Uhlenbeck and Ornstein, 1930). The velocity V (t) takes the form:
dV (t) = −ρ{V (t)− ν̄}dt + σξdW (t), t ∈ Ts, (2.8)
where ρ ∈ R+, ν̄ ∈ R, and σξ ∈ R+. In contrast to the Wiener process, OU process
is a stationary Gaussian process with stationary mean ν̄ and variance σ2ξ/2ρ. σ
2
ξ has
the same interpretation as that of the Wiener process. The instantaneous mean or
the expected conditional acceleration −ρ{V (t) − ν̄} describes how fast the process
moves. The larger the ρ, the more rapidly the process evolves toward ν̄. The farther
V (t) departs from ν̄, the faster the process moves back towards ν̄.
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If the data are equally spaced, namely δj := tj − tj−1 = δ, V (t) coincides with the
first order autogreession(AR(1)) process with autocorrelation exp(−ρδ). The converse
also holds; AR(1) converges weakly to the OU process if δj → 0 (Cumberland and
Sykes, 1982).
2.3 Estimation and Inference
Statistical inference for CDSSM is challenging because we consider a vector of
stochastic processes θ(t) := [U(t), U (1)(t), . . . , U (m−2)(t), V (t)]T simultaneously. This
leads to a complex likelihood function, which may not even exist in closed form.
Since an analytical solution of the SDE is rarely available, the resulting conditional
distribution of θ(t) given θ(t′), for t′ < t, which we call the exact transition density,
does not have a simple closed form expression. Thus exact inference for the latent
processes and its parameters is not generally possible. Hence, a numerical approx-
imation will usually be needed. We will use the Euler approximation of the SDE
to approximate the transition density, which enables us to obtain a simple closed
form of the likelihood. To alleviate the errors associated with this approximation, it
may be helpful to augment the observed data by adding virtual data at extra time
points (Tanner and Wong, 1987), so that the interval between adjacent time points
is shorter and a preciser approximation is achieved. Even when the exact transition
density exists, using the approximated one will significantly simplify the estimation
of parameters φs. A case in the point is the SVM-OU.
The resulting likelihood with this approximate method involves high-dimensional
integrals, and we adopt a Bayesian approach in which we use Markov Chain Monte
Carlo (MCMC, Geman and Geman 1987, Gelfand and Smith 1990, Gilks et al. 1996)
to estimate U(t), V (t) and the parameters (σ2ε , φs) , with the assistance of the simu-
lation smoother(Durbin and Koopman, 2002b).
Different approaches for inference for discretely observed diffusions are reviewed
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by Beskos et al. (2006). These includes numerical approximations to obtain likelihood
functions (Aı̈t-Sahalia, 2002) and methods based on iterated filtering (Ionides et al.,
2006). The idea of Euler approximation has been applied to the stochastic volatility
model in the finance literature. Pedersen (1995) applied the approximation and data
augmentation to facilitate Monte Carlo integration and it was further developed by
Durham and Gallant (2002). Bayesian analysis of the diffusion model, especially the
stochastic volatility model, has been developed by many authors, including Elerian
et al. (2001), Eraker (2001), and Roberts and Stramer (2001). Sorensen (2004) gave
a survey on inference methods for stochastic diffusion models in finance. Distinctions
between the models considered in financial statistics and the models considered in
this paper are that we specify an observation equation to address the measurement
errors. Most methods of inference for diffusion process do not extend easily when
there is measurement errors (Beskos et al., 2006). However, MCMC methods can be
extended. A further distinction is that we consider the case m > 1 for the ODE, and
that we apply the ODE and SDE to model various biomedical phenomena via U(t)
and V (t). Thus, the SVM is focused on estimating the unknown sample paths of
the latent stochastic process U(t) and V (t), whereas the diffusion models commonly
used in the finance literature do not include an observation equation for measurement
errors and typically focus on estimating volatility or variance of the process of interest,
for example, derivative securities.
2.3.1 Likelihood and Euler approximation
To develop Bayesian inference with an MCMC algorithm, we begin with the like-
lihood of the SVM:
[yo | φo, φs, θ0] =
∫ ∫
[yo | U o,V o,φo][U o,V o | θ0,φs]dU odV o,
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where U o := [U(t1), U(t2), . . . , U(tJ)]
T, V o := [V (t1), V (t2), . . . , V (tJ)]
T, and yo :=
[y(t1), y(t2), . . . , y(tJ)]
T are vectors of the latent states and observations at t ∈ To.
θ0 = [U(t0), V (t0)]
T is the unknown initial vector of the latent states, and [· | ·]
denote conditional density. The conditional density of the observations is given by
[yo | U o,V o,φo] =
J∏
j=1
φ(y(tj) | U(tj), σ2ε),
since the observations are mutually independent given the latent states and follow
the normal distribution according to model (2.1), where φ(· | UG, σ2G) is the normal
density function with mean UG and variance σ
2
G. In principle, the density of latent
states U o and V o can be written as:
[U o,V o | θ0,φs] =
J∏
j=1
[ U(tj), V (tj) | U(tj−1), V (tj−1),φs],
due to the Markov property. The exact transition density [U(tj), V (tj) | U(tj−1), V (tj−1),φs)
exists in a closed form only for few models with simple SDEs. Even in those cases,
the exact transition density may have complex form. For SVM-OU,









, ν̄ + {V (tj−1)− ν̄} exp(−ρδj)
]T
,









{−3 + 4 exp(−ρδj)− exp(−2ρδj)} 12ρ2{1− 2 exp(−ρδj) + exp(−2ρδj)}
1
2ρ2
{1− 2 exp(−ρδj) + exp(−2ρδj)} 12ρ{1− exp(−2ρδj)}

 ,
the proof of which is in Appendix C. When using data augmentation, we may take
the component wise first-order Taylor approximation of mOU , V OU with respected to
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δj and get
m̃OU = [U(tj) + V (tj)δj, V (tj)− ρ{V (tj)− ν̄}δj]T, (2.9)









We note that these are the same expressions as those obtained by applying Euler
approximation to SVM-OU. Thus although m̃OU and Ṽ OU as given in (2.9) and
(2.10) are not strictly necessary for calculating [U o,V o | θ0, φs] when mOU and V OU
are available, they however lead to a simpler form for parameter ρ, which is much
easier to be updated and converges much faster in the following MCMC algorithm.
For a general SDE, e.g. (2.3), the forms for U(t) and V (t) are:










b{V (s),φs}dW (s), t ∈ T,s
where [U(tj), V (tj) | U(tj−1), V (tj−1), φs] is implicitly defined but in general is not
available analytically. To deal with this difficulty, we use the Euler approximation to
obtain a numerical approximation of the transition density in the general SDE case.
The Euler approximation is a discretization method for the SDE through the
first-order strong Taylor approximation (Kloeden and Platen, 1992). The resulting
discretized versions of the ODE and the SDE in (2.2) and (2.3) are given by, respec-
tively,
U (J)(tj) = U
(J)(tj−1) + V (J)(tj−1)δj, (2.11)
V (J)(tj) = V
(J)(tj−1) + a{V (J)(tj−1), φs}δj + b{V (J)(tj−1),φs}ηj, tj ∈ To (2.12)
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where δj := tj − tj−1 and ηj := W (tj)−W (tj−1) ∼ N (0, δj). For t ∈ [tj−1, tj], a linear
interpolation takes the form
Ṽ (J)(t) = V (J)(tj−1) +
t− tj−1
tj − tj−1 (V
(J)(tj)− V (J)(tj−1)), t ∈ Ts.
A similar linear interpolation is applied to Ũ (J)(t). Bouleau and Lepingle (1992)
showed that under some regularity conditions, with constant C, the Lp-norm of the
discretization error is bounded and given by:
|| sup
t∈Ts
| V (t)− Ṽ (J)(t) | ||p≤ C
(




This indicates that if J is sufficiently large, which can be achieved when the maximum
of δj is sufficiently small for fixed interval [t1, tJ ], then Ṽ
(J)(t) will be close to its
continuous counterpart V (t) with arbitrary precision.
In the rest of this paper, we assume the δj is sufficiently small and the approxima-
tion is well achieved. To simplify notation. we replace Ṽ (J)(t) with V (t) and Ũ (J)(t)
with U(t), for t ∈ Ts. Under those assumptions, the exact transition density, if it
exists, is well approximated by the approximate transition density, as shown in the
SVM-OU. Note that equations (2.11) and (2.12) imply the approximate transition
densities of U(t) and V (t) are Gaussian for t ∈ To, because they are linear combi-
nations of ηj, U(t0) and V (t0), which are all Gaussian random variables. Under the
Euler approximation, [U o,V o | θ0,φs] degenerates to ≺ V o | V (t0),φs Â because of
equation (2.11), where ≺ · | · Â denotes the approximate conditional density. Conse-
quently, the likelihood based on the approximated processes U(t) and V (t) for t ∈ To
is given by
≺ yo | φo,φs, V (t0) Â=
∫
[yo | V o,φo] ≺ V o | V (t0),φs Â dV o,
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where
[yo | V o,φo] =
J∏
j=1
φ(y(tj) | U(tj), σ2ε),
≺ V o | V (t0), φs Â =
J∏
j=1
≺ V (tj) | V (tj−1),φs Â,
and
V (tj) | V (tj−1), φs ∼ N
(
V (tj−1) + a{V (tj−1),φs}δj, b2{V (tj−1),φs}δj
)
.
In a real data analysis, the Euler approximation may not always achieve the desired
precision, simply because max(δj) for the observations is not sufficiently small. A
solution to this is data augmentation as described in the next subsection.
2.3.2 Data augmentation
If observational time intervals are not short enough, the Euler approximation will
not work well, because linear interpolation of V (t) and U(t) for t ∈ To is not accurate
enough. A solution to reduce the approximation error is simply to add sufficiently
dense virtual data in each time interval and consider the latent states at these times
in addition to those at t ∈ To. The corresponding values of Y (·) at added times can
be regarded as missing data. They will be sampled as part of the MCMC scheme in
the Bayesian analysis.
To carry out data augmentation, we add Mj equally spaced data at times tj−1,1,
. . . , tj−1,Mj over a time interval (tj−1, tj]. Denote δMj :=
δj
Mj+1
. The resulting aug-
mented index set is Tao = {tj,m : j = 0, 1, . . . , J,m = 0, 1, 2, . . . , Mj,MJ = 0}. Note
that Tao = To, if Mj = 0 for all j. The observed data and the augmented data are de-
noted by yo := [y(t1,0), y(t2,0), . . . , y(tJ,0)]








tively, where ya,j := [y(tj,1), y(tj,2), . . . , y(tj,Mj)]
T. We also denote V := [V T1 , V
T






V j := [V (tj,0), V (tj,1), . . . , V (tj,Mj)]
T. Similar notation is applied to U and U j. For
ease of exposition, we let yj,m := y(tj,m), and similarly for other variables.
If the exact transition densities exist, the augmented likelihood is
[yo | φo,φs,θ0] =
∫ ∫ ∫
[yo,ya | U , V ,φo][U ,V | θ0,φs] dya dU dV ,
where





φ(yj,m | Uj,m, σ2ε),





[ Uj−1,m, Vj−1,m | Uj−1,m−1, Vj−1,m−1,φs].
If the exact transition densities do not exist, the discretized versions of the ODE and
the SDE are modified from t ∈ To to t ∈ Tao given as follows:
Uj−1,m = Uj−1,m−1 + Vj−1,m−1δMj ,
Vj−1,m = Vj−1,m−1 + a{Vj−1,m−1,φs}δMj + b{Vj−1,m−1,φs}ηj−1,m,
where t0,0 := t0, tj−1,Mj+1 := tj,0, and ηj−1,m := W (tj−1,m)−W (tj−1,m−1) ∼ N (0, δMj).
The approximate transition density and the corresponding likelihood are given in
Section 2.3.3.
2.3.3 Bayesian inference
MCMC enables us to draw samples from the joint posterior [θ0,V ,φo,φs | yo],
or in the case of data augmentation, [θ0, V ,φo,φs,ya | yo]. We use the approximate
transition density to obtain the likelihood and apply the data augmentation technique
whenever necessary.
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MCMC draws samples from [θ0,V ,φo, φs,ya | yo] by iteratively simulating from
each full conditional density of θ0,V , φo,φs, and ya. The joint posterior density is
proportional to the product of the likelihood and prior densities:
[θ0,V ,φo, φs,ya | yo] ∝ [yo | θ0,V ,φo,φs][ya | θ0,V ,φo, φs] ≺ V | θ0, φs Â
× [θ0][φs][φo],
where
[yo | θ0,V , φo, φs] =
J∏
j=1
φ(yj,0 | Uj,0(θ0,V ),φo),





φ(yj,m | Uj,m(θ0,V ),φo),





≺ Vj−1,m | Vj−1,m−1,φs Â,
and Vj−1,Mj+1 = Vj,0 . The approximate transition density ≺ Vj−1,m | Vj−1,m−1, φs Â
with augmented data is given by,
≺ Vj−1,m | Vj−1,m−1,φs Â:=
φ(Vj−1,m | Vj−1,m−1 + a{Vj−1,m−1,φs}δMj , b2{Vj−1,m−1,φs}δMj),
and [θ0], [φs], [φo] are non-informative prior densities. See the Appendix A for spec-
ification of the prior distributions and details of MCMC algorithm. Note that we use
the simulation smoother(Durbin and Koopman, 2002b) to achieve an efficient MCMC
algorithm. In the simulation smoother, the latent states are recursively backward
sampled in blocks instead of one state at a time. This leads to low autocorrelation
between successive draws, and hence faster convergence.
A desirable property of this approach is the ease of deriving forecasts of states at
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future times, which is of great interest in some studies.
2.3.4 Posterior forecasting with SVM
To forecast the k-step future latent state θfJ+k given the observations yo, we
simulate θfJ+k from the following posterior forecasting distribution,
[θfJ+k | yo] =
∫ ∫ ∫
[θfJ+k | ya,yo,φs,φo][ya,φs, φo | yo] dya dφs dφo,
where ya,φs and φo are drawn from [ya,φs,φo | yo] by the MCMC algorithm. Given
ya, φs and φo, we first discretize the SVM. For SVM-OU, this will lead to equations
(A.1) and (A.2) in Appendix A. Let θJ denote the latent state of the last observation.
Then, E(θJ) = aJ and Var(θJ) = RJ are obtained via the Kalman filter. Moreover,





J+k−1 + ΣωJ+k−1 , k = 1, 2, . . . ,
where GJ+k−1 and ΣωJ+k−1 are specified in Appendix A for the SVM-OU and SVM-
Ws, respectively. Finally, we draw θfJ+k from θ
f
J+k | ya,yo,φs,φo ∼ N (aJ+k, RJ+k).
By this way, the forecasts of states at future times take the variation of parameter
draws into consideration.
2.4 Application
We now demonstrate an application where the diffusion models are used to inves-
tigate dynamic features of the PSA profile for a prostate cancer patient. We fit the
SVM and SAM with the Wiener process and the OU process V (t), respectively. We
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also forecast the future profile of PSA for both models. The models are evaluated by
the DIC model selection criterion(Speigelhalter et al., 2003). DIC = D̄ + PD, where
D̄ is posterior mean of the deviance and PD is the effective number of parameters.
DIC has been shown asymptotically to be a generalization of Akaikes information
criterion. The smaller the DIC value indicates better model-fitting. For each appli-
cation, the posterior draws are from a 400, 000 iteration chain with 200, 000 burn-in,
and every 100th draw is selected. Convergence was assessed by examination of trace
plots and autocorrelation plots.
2.4.1 Prostate specific antigen
PSA is a biomarker used to monitor recurrence of prostate cancer after treatment
with radiation therapy. When PSA remains low and its rate varying around zero with
low volatility, the tumor is stable and the patient may be cured. If PSA increases
dramatically with high rate, it is a strong sign of the tumor re-growing and that the
treatment did not cure the patient. Therefore, PSA has strong prognostic significant
and is important for making clinical decisions. We want to estimate dynamics of
the PSA marker, including PSA level, rate and the volatility of rate. Yu et al.
(2008) applied a joint longitudinal survival-cure model to make individual prediction
of cancer recurrence, where the “true” PSA trajectory is specified by a nonlinear
exponential decay and growth model(Zagars and Pollack, 1993),
PSA(t) = r1 exp(−r2t) + r3 exp(r4t),
where r1,r2,r3 and r4 are parameters. We analyzed the PSA profile of one patient
using the SVM and SAM model to estimate PSA(t) nonparametrically. For these data
illustrated in the introduction, the average time interval between two observations was
0.4 years with minimum 0.016 and maximum 0.731 years. we added 32 virtual data
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points to reduce the time span between any pairs of consecutive time points to less
than 0.25 year.
Table 2.1 and 2.2 shows the means and quantiles of the SVM and SAM parameters
from the Wiener and the OU process V (t), respectively. Figure 2.2 and 2.3 shows
the posterior means and the corresponding 95% credible intervals of the latent states
for SVM and SAMs. Here, the four models demonstrate similar trends of the PSA
level. However, the rates in the SVMs fluctuates with higher volatility, compare
to the SAMs. In addition, there are the non-zero instantaneous mean terms in the
SVM-OU and SAM-OUs, whose rates evolve more stably than those in the models
with Wiener process. The SVM-OU gives the smallest DIC, which indicates the best
model fitting. In this model, the posterior mean of ν̄ is 0.385 with 95% credible
interval [0.143, 0.626]. This stable and clearly positive rate after year 2.2 is a strong
indicator of prostate cancer recurrence.
Figure 2.4 illustrates the forecasting of the PSA latent states for the next 3 years,
starting from year 11.2, by SVM-W and SVM-OU. The future states are sampled
every 0.25 years and then linearly interpolated, from the posterior forecasting distri-
bution given in Section 3.4. The SVM-OU gives a forecast with narrower credible
intervals than the SVM-W. This result seems clinically more sensible, because several
studies, including ours presented in Section 4.2, have found that the rate of PSA fol-
lows a stationary process. In contrast, Wiener process corresponds to a nonstationary
process for the rate of PSA, resulting in an unbounded variance of the forecast over
time. This lacks relevant clinical interpretation. The comparison in the forecasts
indicates that specification of the latent process is crucial for adequate forecasting,
even though their estimates of the mean function are quite similar. A similar phe-
nomenon has been reported by Taylor and Law (1998) in the linear mixed model of
CD4 counts, where the covariance structure matters for individual level predictions,














































Figure 2.2: PSA: Plots of data points(◦), posterior means(—) and 95% credible inter-
vals(gray shades) for the SVM with the Wiener process and OU process,
respectively. In the graph the upper panels show the rate, V (t), and the




































































Figure 2.3: PSA: Plots of data points(◦), posterior means(—) and 95% credible inter-
vals(gray shades) for the SAM with the Wiener process and OU process,
respectively. In the graph, the upper panels show the acceleration V (t),















































































Figure 2.4: PSA Forecasting: Plots of posterior means(—) and 95% credible inter-
vals(gray shades) for the SVM with the Wiener process and OU process,
respectively, till year 11.2. The future rates and levels are forecasted
for the next 3 years, illustrated by the forecasting means (—) and 95%
forecasting credible intervals(gray shades). The 5 randomly picked real-
izations for each plot are also illustrated.
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Table 2.1: PSA data:Posterior mean and quantiles for the SVMs.
Wiener Process OU Process
D̄ = −45.1757, PD = 12.303, DIC = −32.873 D̄ = −45.935, PD = 10.658, DIC = −35.277
Mean SD 2.5% 50% 97.5% Mean SD 2.5% 50% 97.5%
σ2ε 0.014 0.009 0.003 0.012 0.036 0.012 0.005 0.005 0.012 0.024
σ2ξ 0.961 0.589 0.297 0.809 2.548 0.177 0.181 0.037 0.122 0.682
ν̄ 0.385 0.124 0.143 0.382 0.626
ρ 1.150 0.271 0.756 1.106 1.798
Table 2.2: PSA data:Posterior mean and quantiles for the SAMs.
Wiener Process OU Process
D̄ = −34.812, PD = 8.985, DIC = −25.827 D̄ = −38.867, PD = 6.213, DIC = −32.654
Mean SD 2.5% 50% 97.5% Mean SD 2.5% 50% 97.5%
σ2ε 0.018 0.007 0.009 0.017 0.036 0.015 0.005 0.008 0.015 0.028
σ2ξ 0.386 0.408 0.074 0.275 1.327 0.011 0.095 0.000 0.002 0.043
ν̄ −0.119 0.048 −0.193 −0.122 −0.004
ρ 0.741 0.170 0.573 0.723 0.990
2.5 Discussion
Diffusion type models are widely applied in areas such as finance, physics and
ecology. However, other than through the connection with the smoothing spline, they
have not played a major role in functional data analysis or nonparametric regression.
In this paper we develop a framework that sheds light on more general diffusion models
to be used in functional data analysis. Unlike in some applications where the form of
the diffusion model is determined by the context, we specify a general form based on
an ODE, a SDE and measurement error. The key advantage of the proposed diffusion
model is that is addresses not only the mean function nonparametrically but also its
dynamics, which are also of great interest in many application. Based on this model
we adapt and develop existing ideas for estimation and inference for diffusion models.
An additional attractive feature of this stochastic model approach to functional data
analysis is that forecasting can be easily implemented.
As noted above, the SVM with the Wiener process corresponds to the smoothing
spline with m = 2. If no augmented data are involved, the model can be rewritten as a
linear mixed model for both situations of exact and approximate transition densities.
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As shown in the Appendix B, when data are equally spaced, the latter case is identical
to a linear spline model with truncated line function basis (Ruppert et al., 2003). In
this sense, the linear spline model can be regarded as a numerical approximation of
the smoothing spline. In addition, with no data augmentation, one can easily fit the
SVM with the Wiener process using existing software for the linear mixed model.
A number of extensions of the SVM and SAM are possible. Generalizing SVM
and SAM to analyze discrete-valued outcomes is of interest. For the SVM, we have
an explicit expression for the observation equation given by:














= F Tθ(tj) + ε(tj), j = 1, 2, . . . , J.
The observation equation can be expressed as,
d Φ{Y (t) | F Tθ(t), σε}, t ∈ To, (2.13)
where Φ(· | UG, σG) is the normal CDF with mean UG and standard deviation σG.
Then, (2.13) can be extended to,
d F{Y (t) | θ(t), φo},
where one specifies the corresponding observation distribution F in the exponential
family, with state equations (2.2) and (2.3) unchanged.
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CHAPTER III
Semiparametric Stochastic Modeling of
the Rate Function in Longitudinal Studies
3.1 Introduction
This chapter focuses on semiparametric stochastic modeling of rate functions for
functional data in a multi-subject setting, where the data consists of a set of subjects,
and for each subject, the observations are discrete samples from a curve with added
measurement errors. The rate function describes the functional rate of change or
slope with respect to time, a quantity which has been recently of great interest in
longitudinal biomedical studies (Mungas et al., 2005; Lloyd-Jones et al., 2007; Strasak
et al., 2008; Kariyanna et al., 2009). For example, from subject-matter knowledge it
may be the rate of change, rather than the level of some biomarker, that can explain
and predict the disease outcomes. A challenge in this research is to model the rate
function without making a strong parametric assumption. Further challenges include
modeling the rate functions across subjects as well as a function of the covariates of
interest.
Our development has been largely motivated by a longitudinal study in prostate
cancer patients (Proust-Lima et al., 2008a), where prostate-specific antigen(PSA) pro-
files were collected for patients who received external beam radiation therapy(EBRT).
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PSA is roughly proportional to the prostate tumor size, and its rate of change has
been shown to be associated with the recurrence of prostate cancer (Sartor et al.,
1997). Figure 3.1(a) shows the log-transformed PSA level over time after EBRT
treatment for 50 selected patients, and Figure 3.1(b) illustrates individual empiri-
cal rates of change, one for each subject. Figure 3.1(b) suggests that the individual
rate of change in PSA follows roughly a common pattern. That is, it begins with
a negative value caused by the EBRT, decreases over time in magnitude when the
rate of tumor shrinkage gets lower, and eventually reaches a certain stable level. It is
also apparent that rates of change vary considerably from this common pattern. For
example, for the subject highlighted in black, his empirical rate of change fluctuates
around zero and his PSA level appears very different from the others. Hence it is
desirable to model the rate of change semiparametrically by incorporating empirical
evidence or prior knowledge through a parametric function of time while accounting
for deviation from the common pattern nonparametrically. Additionally, it is clear
that for some subjects the long term stable rates of change are near zero, while for
others they are positive. It is thus appealing not only to model a common stable
rate of change across subjects but also to let it follow a distribution, say a normal
distribution with its mean depending on some baseline covariates. This flexibility will
benefit the forecasts of future observations.
A number of methods have been used to study the rate of change in longitudinal
studies. A popular approach is through a parametric linear mixed model (Laird
and Ware, 1982; Diggle et al., 2002; Verbeke and Molenberghs, 2009), for example
the random intercept and slope mixed model for disease progression (Zhang et al.,
2008). This model assumes the subject’s mean function follows a straight line with
constant rate of change, which in turn is dependent on the covariates. In contrast to
parametric models, the mean function have be modeled nonparametrically (Rice and
Silverman, 1991; Wang and Taylor, 1995; Zeger and Diggle, 1994; Zhang et al., 1998;
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tij−ti,j−1 , for the give subject i with observation Yij at
time tij. All profiles are plotted as the gray solid lines, except one profile
highlighted in black color.
Verbyla et al., 1999). Consequently, the resulting rate function, as the first order
derivative of the mean function, does not have any parametric form, and usually
it is not dependent on covariates. Additionally, in a time-varying coefficient model
(Hastie and Tibshirani, 1993; Hoover et al., 1998) or functional mixed model (Guo,
2002; Morris and Carroll, 2006), the mean function Ui(t) of the ith subject is specified
as Ui(t) =
∑K
k=0 Xikβk(t) and Ui(t) = Xi0β0(t) + Xi1βi1(t), respectively. Hence, Ui(t)
is a linear combination of several arbitrary smooth functions βk(t) or the summation
of smooth functions β0(t) and βi1(t), with covariates Xik as the weights. As the
result, the rate function depends on covariates through linear combinations. Thus
there seems to be a need for a model that allows flexible relationships between the
rate function and covariates. Moreover, note that except for a few approaches (Qin
and Guo, 2006; Welham et al., 2006), nonparametric approaches seldom incorporate
any prior knowledge from the subject-matter science, if available, in the modeling of
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the shape of the rate function.
Our goal is to develop a semiparametric stochastic model for the analysis of
the rate function, which is called in this paper a semiparametric stochastic velocity
model(SSVM). A key feature of SSVM is to utilize a stochastic process as a prior for
the rate function, in a similar spirit to the work of Wahba (1978). Formally, for each
rate function Vxi(t) ∈ R with subject i ∈ N = {1, 2, . . . , n} and time t ∈ Ts = [0,∞),
its prior is assumed to be a Gaussian process, conditional on xi = (xi0, xi1, . . . , xip)
T,
the vector of covariates for the ith subject. As an important special case of the pro-
posed SSVM, we consider Vxi(t) = fxi(t)+σξWi(t), with fxi(t) having a pre-specified
parametric functional form dependent on covariates xi, and σξWi(t) a scaled stan-
dard Wiener process. Hence, E{Vxi(t)} = fxi(t) implies that Vxi(t), the rate function
of the ith subject, is expected to be centered about fxi(t), while the second term
σξWi(t) allows deviations from the parametric functional expectation fxi(t).
The remainder of the chapter is organized as follows. Section 3.2 presents first the
model and then is devoted to an important special case with the Ornstein-Uhlenbeck
process as the prior for the rate function. Section 3.3 develops MCMC based methods
for posterior inference and forecasting. Section 3.4 applies the methods to analyze the
data of PSA profiles. Section 3.5 presents simulation results to evaluate and compare
the performance of the proposed method with other existing methods. The chapter
concludes with a discussion in Section 3.6.
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3.2 Semiparametric Stochastic Velocity Model
3.2.1 Model Specification
Suppose that Yi(tij), j = 1, 2, . . . ,mi, i = 1, 2, . . . , n, is the response of the ith
subject at time tij and satisfies the following hierarchical model, SSVM:
Yi(t) = Uxi(t) + εi(t), t ∈ Tio = {tij : ti1 < ti2 < · · · < timi}, (3.1)
dUxi(t) = Vxi(t)dt, t ∈ Ts = [t0,∞), (3.2)
dVxi(t) = a{Vxi(t); xi,φi}dt + b{Vxi(t); xi,φi}dWi(t), t ∈ Ts, (3.3)
where Uxi(t) is the mean function for the ith subject’s outcome curve , Vxi(t) is the
corresponding rate function and Wi(t) denotes the standard Wiener process. Note
that in this specification, although the mean function is defined at continuous times
Ts, it is observed at discrete times Tio only and is subject to measurement error.
Equation (3.3) may be regarded as a prior for the rate function Vxi(t), in which the
behavior of Vxi(t) is governed by the stochastic differential equation(SDE), with drift
term a{Vxi(t); xi,φi} and diffusion term b{Vxi(t); xi, φi}, where xi and φi are the
covariate vector and subject-specific parameter vector. We assume that the initial
values [Uxi(t0), Vxi(t0)]
T iid∼ N2(0, σ20I2) with large value of variance σ20 to make it
non-informative, and that the measurement error εi(t)
iid∼ N (0, σ2ε). Here Ik is the
k × k identity matrix and Nk(m,Σ) denotes the k-dimensional normal distribution
with mean vector m and covariance matrix Σ. Furthermore, [Uxi(t0), Vxi(t0)]
T, εi(t)
and Wi(t) are assumed mutually independent.
The SDE in equation (3.3) gives rise to a general class of Markovian Gaussian
processes (Feller, 1970; Grimmett and Stirzaker, 2001). In our model, this stochastic
process is considered as the prior for the rate function Vxi(t). According to the specific
research interests or contexts of a given study, we can choose different forms for
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a{Vxi(t); xi,φi}, which measures the instantaneous mean or the expected conditional
acceleration, and for b2{Vxi(t); xi,φi}, which reflects the instantaneous variance of
the rate process. In particular, we have the SSVM-W, with a{Vxi(t); xi,φi} = 0
and b{Vxi(t); xi,φi} = σξ, and the prior for Vxi(t) is the Wiener process. Thus the




which is the partially integrated Wiener process leading to a smoothing spline (Wahba,
1978; Wecker and Ansley, 1983; Ansley and Kohn, 1986) for a given subject. Note
that this prior is independent of covariates.
For the PSA data analysis given in Section 3.4, we specify a{Vxi(t); xi,φi} =
−ρ{Vxi(t) − ν̄i(xi, β)} and b{Vxi(t); xi,φi} = σξ. This specification corresponds to
an Ornstein-Uhlenbeck(OU) process for Vxi(t), and the resulting rate function is given
by Vxi(t) = fxi(t) + σξWi(t) = Vxi(t0)−
∫ t
t0
ρ{Vxi(s)− ν̄i(xi,β)} ds + σξWi(t). More
details and properties of the OU process can be found in Section 3.2.2 below. We
refer to this specification as SSVM-OU. For the PSA data analysis, it is of interest to
estimate the stable rate ν̄i(xi, β), since Vxi(t) will eventually stabilize and fluctuate
around the level given by ν̄i(xi, β), which describes the long term rate of tumor
growth after radiation treatment. In addition, to address the relationship between
the long term tumor growth rate ν̄i(xi, β) and the patients’ baseline characteristics,
we propose a linear model ν̄i(xi,β) = νi + x
T
i β, where β = (β0, β1, . . . , βp)
T is the
vector of fixed effects parameters and νi
iid∼ N (0, σ2ν) are random effects. This subject-
specific SSVM-OU is very useful to understand the dynamics of tumor growth, to
assess the effect of coefficients, and to predict a patient’s future PSA values using the
baseline covariate information.
3.2.2 The OU and IOU Processes
The OU process was first proposed as a physical model for the velocity of a particle
suspended in a fluid (Uhlenbeck and Ornstein, 1930). It describes a homeostasis sys-
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tem that fluctuates around some stable level and has been applied in biology (Trostab
et al., 2009), finance (Nicolato and Venardos, 2003) and engineering (Kulkarni and
Rolski, 2009), among many others. In the statistics literature, Aalen and Gjessing
(2004) studied the first-passage time of an OU process, and Taylor and Law (1998)
modeled the serial correlation in a linear mixed model by an integrated OU(IOU)
process with mean zero. This process is particularly suitable for the PSA profiles
considered in this paper, where the rate function of tumor growth reaches the stable
level that may depend on baseline covariates.
Now we present some properties for both the OU and IOU processes. For ease of
exposition, we suppress the subject index i in the discussion. Let Uj := U(tj) and
Vj := V (tj). The OU and IOU processes are given by, respectively,
dU(t) = V (t)dt, (3.4)
dV (t) = −ρ{V (t)− ν̄}dt + σξdW (t). (3.5)
Theorem 1. For IOU and OU processes at time tj, conditioned on the values at time
tj−1 and parameters ν̄, ρ, σξ. We have
Uj, Vj | Uj−1, Vj−1, ν̄, ρ, σξ ∼ N2(mj,Σj),
δj = tj − tj−1, with conditional mean and covariance matrix given, respectively, by,
mj =
[

















{−3 + 4 exp(−ρδj)− exp(−2ρδj)} 12ρ2{1− 2 exp(−ρδj) + exp(−2ρδj)}
1
2ρ2
{1− 2 exp(−ρδj) + exp(−2ρδj)} 12ρ{1− exp(−2ρδj)}

 .
The proof is in Appendix C.






conditional mean and variance from in Theorem 1 can be approximated by,


























































transition density denoted by ≺ Uj, Vj | Uj−1, Vj−1, ν̄, ρ, σξ Â is given by,
≺ Uj, Vj | Uj−1, Vj−1, ν̄, ρ, σξ Â =≺ Vj | Vj−1, ν̄, ρ, σξ Â δ(Uj − Uj−1 − Vj−1δj)
= φ(m̃j, Σ̃j)δ(Uj − Uj−1 − Vj−1δj)
where φ(m̃j, Σ̃j) is the normal density with mean m̃j = Vj−1 − ρ{Vj−1 − ν̄}δj and
variance Σ̃j = σ
2
ξδj, and δ(·) is the Dirac Delta function.
This corollary can be proved by taking the component-wise first-order Taylor
approximation of mj and Σj in Theorem 1 with respected to δj.
3.3 Inference and Forecasting
3.3.1 Inference
In this section, we present Bayesian estimation for the mean function Uxi(t), the
rate function Vxi(t) and parameters φi and σε with i = 1, 2, . . . , n and t ∈ Ts1 = [t :
t0 ≤ t ≤ tm]. Let [· | ·] denote the exact conditional density, ≺ · | · Â the approximate
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conditional density and U = [UT1 ,U
T
2 , . . . , U
T
n ]
T with U i = [Ui1, Ui2, . . . , Uimi ]
T.
Similar notation is used for V ,Y and x. For the model specified by equations (3.1),
(3.2) and (3.3), we first consider the posterior density [φ | U ,V , Y , x] for φ, where
φ = [φT1 ,φ
T
2 , . . . , φ
T
n ]
T. The posterior distribution is given by





[Uij, Vij | Ui,j−1, Vi,j−1, φi, xi][U0, V0][φi], t ∈ Tio (3.6)
where [Uij, Vij | Ui,j−1, Vi,j−1,φi,xi] is the exact transition density derived from the
SDE in equation (3.3) and [U0, V0] and [φi] are non-informative prior densities. Un-
fortunately, except for a very few specific forms for the drift and diffusion terms in
equation (3.3), [Uij, Vij | Ui,j−1, Vi,j−1,φi,xi] is usually analytically intractable. Even
when the exact transition density does have a closed form, as is the case for the OU
and IOU processes, where the exact transition density is given in Theorem 1, the
posterior density for φ still does not have an explicit form. Hence, we will use the
Euler approximation to approximate the exact transition density, while applying the
method of data augmentation (Tanner and Wong, 1987) to minimize the error in this
approximation.
The strategy of combining data augmentation and Euler approximation to ap-
proximate the exact transition density has been discussed by Elerian et al. (2001),
Eraker (2001), Roberts and Stramer (2001) and Durham and Gallant (2002), in the
context of estimating parameters in the SDE for a single diffusion process observed
at discrete times with no measurement errors. Our approach is related to theirs,
but with an important distinction that instead of being partially observed, both pro-
cesses Vxi(t) and Uxi(t) are completely unobserved, and will be sampled as part of
an MCMC algorithm. In this manner, we will be estimating the processes Vxi(t) and
Uxi(t), as well as estimating the parameters φ.
To carry out the data augmentation and the Euler approximation, we first specify
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time points at which data would be augmented. Let Tia = [t : t = tij + kτij, τij =
ti,j+1−tij
Mij
< τc, t ∈ (tij, ti,j+1), k = 1, 2, . . . ,Mij, j = 1, 2, . . . , mi − 1] denote the set of
augmentation times for the ith subject. Consequently, the time interval τij between
adjacent data points, either observed or augmented, is less than τc. In addition, let
T = ∪ni=1 (Tio ∪ Tia) = [t : tj, j = 1, 2, . . . , m] denote the set of all possible time
points of the observed and augmented data across all subjects. With further data
augmentation at times t ∈ Tim = [t : t ∈ T , t /∈ Tio, t /∈ Tia], each subject would
have either observed or augmented data Ỹ i = [Yi1, Yi2, . . . , Yim]
T at the common time
set T . The Euler approximation to equations (3.2) and (3.3) for t ∈ T leads to the
following difference equations:
Uij = Ui,j−1 − Vi,j−1δj, (3.7)
Vij = Vi,j−1 + a{Vi,j−1; xi, φi}δj + b{Vi,j−1; xi,φi}(Wj −Wj−1), (3.8)
where Wj − Wj−1 ∼ N1(0, δj) and j = 1, 2, . . . , m. Thus, the conditional posterior
density for φ is approximated by,





≺ Uij, Vij | Ui,j−1, Vi,j−1, φi,xi Â [U0, V0][φi], (3.9)




2 , . . . , Ũ
T
n ]
T with Ũ i = [Ui1, Ui2, . . . , Uim]
T and similarly for Ṽ and
Ỹ . Note that the approximate transition density ≺ Uij, Vij | Ui,j−1, Vi,j−1, φi, xi Â in
equation (3.9) is given by,
≺ Uij, Vij | Ui,j−1, Vi,j−1, φi, xi Â = N1
(
Vi,j−1 + a{Vi,j−1; xi,φi}δj, b2{Vi,j−1; xi,φi}δj
)
× δ(Uij − Ui,j−1 − Vi,j−1δj), (3.10)
which is derived from equations (3.7) and (3.8). This implies that it is feasible to
directly sample from the posterior distribution of φ, if the conjugate priors for φ are
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chosen.
With regard to the posterior samples of Uxi(t) and Vxi(t) for t ∈ Ts1 , we follow





xi (t), with linear interpolation for t between tj−1 and tj for j = 1, 2, . . . , m.
Bouleau and Lepingle (1992) showed that under some regularity conditions, with
constant Ci, the L








| Vxi(t)− V (m)xi (t) | ||p≤ Ci
(




This indicates that if m is sufficiently large, then V
(m)
xi (t) will approach to its contin-
uous counterpart Vxi(t) with arbitrary precision. Similar arguments hold for U
(m)
xi (t).
Note that we will sample m instead of mi data points for U
(m)
xi (t) and V
(m)
xi (t) with
possibly m À mi. Hence, the benefit of introducing augmented data is two fold: (i)
it reduces the error of approximation, when U
(m)
xi (t) or V
(m)





xi (t), is used to replace Uxi(t) or Vxi(t); (ii) it gives a more accurate approxima-
tion for the exact transition density, as suggested by Pedersen (1995), which benefits
estimation of model parameters φ. Under the assumption that m is large enough such
that the approximation error is small, for the ease of exposition, we still use Vxi(t)
instead of V
(m)
xi (t) throughout the rest of the chapter. Uxi(t) is treated similarly.
In the MCMC algorithm to update the values of Uxi(t) and Vxi(t) for t ∈ t0
⋃ T ,
we draw samples from





[Ỹij | Uij, σ2ε ] ≺ Uij, Vij | Ui,j−1, Vi,j−1,φi,xi Â
× [U0, V0], (3.11)
where [Ỹij | Uij, σ2ε ] = φ(Uij, σ2ε), ≺ Uij, Vij | Ui,j−1, Vi,j−1,φi,xi Â is given in equation
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(3.10) and [U0, V0] is non-informative prior. Equivalently, the posterior density (3.11)
may be derived from a state space model representation(Durbin and Koopman, 2001),
which is a useful reformulation of the SSVM in equations (3.1), (3.2) and (3.3) when
it is discretized using the Euler approximation and data augmentation.
Consider an example where Vxi(t) follows the OU process and
≺ Uij, Vij | Ui,j−1, Vi,j−1, φi, xi Â is given in Corollary 2. Let Ỹ j = [Ỹ1j, Ỹ2j, . . . , Ỹnj]T
denote the observed or augmented data for n subjects at time tj, and let θj =
[θT1j,θ
T
2j, . . . , θ
T
nj]
T be the latent states with θij = [Uxi(tj), Vxi(tj), ν̄i(xi,β)]
T. The
corresponding SSVM can be expressed as a state space model, given as follows:
Ỹ j = F
T
j θj + εj, εj ∼ Nn(0, σ2εIn)
θj = Gjθj−1 + ξj, ξj ∼ N3n(0, σ2ξIn ⊗Σj)


















Likewise, when Vxi(t) follows a Wiener process, the corresponding reformulation as a
state space model can be obtained in a similar manner.
3.3.2 MCMC Algorithm
Under this state space model reformulation, both latent states Uxi(t) and Vxi(t)
at times t ∈ to
⋃ T could be sampled by using the simulation smoother(de Jong
and Shephard, 1995; Durbin and Koopman, 2002b), an efficient MCMC algorithm to
sample the latent states simultaneously in blocks instead of one variable at a time,
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and thus the convergence of the algorithm is fast.
The proposed MCMC algorithm iterates through the following steps.
1. Draw augmented data according to Yi(t) ∼ N (Uxi(t), σ2ε) at times t ∈ Tia
⋃ Tim
for the ith subject, i = 1, 2, . . . , n.
2. Update latent states Uxi(t) and Vxi(t) for t ∈ t0
⋃ T from the posterior density
(3.11) by using the simulation smoother.
3. Update φ by sampling from the posterior density (3.9). In particular, when
Vxi(t) follows an OU process and is discretized through the Euler approximation,
the collection of equations (3.8) could be equivalently reformulated as a linear
mixed model,




∗ + ξ∗j ,
where Y ∗j =
V j−V j−1√
δj









V j = [V1j, V2j, . . . , Vnj]
T and X = [xT1 , x
T
2 , . . . , x
T
n ]
T. Further, β∗ = [ρβT,−ρ]T,
b∗ = ρν, ν = [ν1, ν2, . . . , νn]T, ξ
∗
j ∼ Nn(0, σ2ξIn), b∗ ∼ Nn(0, ρ2σ2νIn). As a
result, the set of model parameters is φ∗ = [β∗, b∗, σ2ξ , ρ
2σ2ν ]
T, which can be
sampled straightforwardly by using the standard Gibbs sampler in the linear
mixed model (Ruppert et al., 2003, Chap. 16) with non-informative conjugate
priors, β∗ ∼ Np+2(0, σ2β∗Ip+2), σ2ξ ∼ IG(Aξ, Bξ), and ρ2σ2ν ∼ IG(Ab∗ , Bb∗). Here
IG(A,B) denotes the inverse gamma distribution with shape parameter A and
scale parameter B.
4. Update σ2ε by sampling from the following posterior density











where the prior distribution for σ2ε is IG(Aε, Bε).
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3.3.3 Bayesian Posterior Forecasting
The proposed model is useful to forecast processes of interest, including Uxi(t),
Vxi(t) and Yi(t), for t ∈ Ts2 = [t : t > tm]. With the availability of posterior samples
for Uxi(t), Vxi(t), φi and σε with i = 1, 2, . . . , n and t ∈ Ts1 = [t : t1 ≤ t ≤ tm], it
is straightforward to derive Bayesian posterior forecasting. Note that the posterior
forecasting distributions are,
[Uxi(t), Vxi(t) | Y ,x] =
∫ ∫ ∫
[Uxi(t), Vxi(t) | Uxi(tm), Vxi(tm),φi,x]×
[Uxi(tm), Vxi(tm),φi | Y ,x]dUxi(tm)dVxi(tm)dφi,
and
[Yi(t) | Y ,x] =
∫ ∫ ∫
[Yi(t) | Uxi(t), σ2ε ][Uxi(t), Vxi(t) | Y ,x]×
[σ2ε | Y ,x]dUxi(t)dVxi(t)dσ2ε ,
Thus, we draw U rxi(t), V
r
xi
(t) and Y ri (t) from [U
r
xi
(t), V rxi(t) | U rxi(tm), V rxi(tm),φris,x]
and [Y ri (t) | U rxi(t), σ2 rε ] for r = 1, 2, . . . , R, where [U rxi(tm), V rxi(tm)]T,φris and σ2 rε
are the rth posterior samples from the MCMC algorithm. When [Uxi(t), Vxi(t) |
Uxi(tm), Vxi(tm),φi,x] does not have a closed form, the approximate transition den-
sity ≺ Uxi(t), Vxi(t) | Uxi(tm), Vxi(tm),φi,x Â could be used instead along with data
augmentation.
3.4 Application to the PSA Data
We apply the proposed SSVM-OU to analyze the PSA data discussed in Section
3.1. The prior of the rate function Vxi(t) is assumed to be the OU process with
a{Vxi(t); xi,φi} = −ρ{Vxi(t)− ν̄i(xi,β)} and b{Vxi(t); xi,φi} = σξ in equation (3.3).
45
A total of 739 observations are obtained for 50 subjects. The number of observations
for each subject varies from 13 to 24. The initial observation after EBRT treatment
is obtained at the first month or 0.083 year, and the time for the last observation
ranges from 3.833 to 8.083 years, with the average of 6.050 years. To reduce the
approximation error discussed in Section 3.3.1, we further augment the data to let
the time interval between adjacent data points, either observed or augmented, be less
than 0.0208 years. The appropriateness of this choice of time interval is confirmed
using the simulation studies in Section 3.5. We investigate the association of the
pretreatment covariates baseline PSA, Gleason score and T stage with the stable
PSA rate via the model ν̄i(xi,β) = νi + β0 + β1XPi + β2XT i + β3XGi, where the
random effect νi ∼ N (0, σ2ν); XPi denotes the log-transformed baseline PSA for the
ith subject, centered around the mean of 2.3; XGi is equal to 1 if Gleason score is
above or equal to level 7, 0 otherwise ; XTi takes the value of 1 if T stage is at level
2 or higher, 0 otherwise. We leave out the last observation for each subject as well
as the observations after year 5 as validation data to assess the forecasting ability of
the model.
The posterior draws are obtained from the proposed MCMC algorithm with 20,000
iterations, discarding the first 10,000 as the burn-in stage and subsequently saving
every 10th draws. The trace plots suggest the algorithm converges fast and mixes well.
Table 3.1 presents the posterior summary statistics for the parameters. Baseline PSA
and T stage are found to have significant effect on the PSA stable rate. This result
suggests that Baseline PSA and T stage are predictive of the long term rate of change
for PSA, which is in agreement with the finding by Lieberfarb et al. (2002). Figure
3.2 displays E[Vxi(t) | Y ], the posterior means of the rate function for each subject
(shown as dashed lines), and E[V (t) | Y ] = E[E[Vxi(t) | Y ]], the posterior mean of
the rate function in the population(shown as solid line). It is clear that although the
rate function in the population level is smooth and may be specified by a parametric
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form, the individual rate functions are much more wiggly, vary significantly across
subjects and would be difficult to model parametrically. Figure 3.3 shows the posterior
means and credible intervals of Uxi(t) for six randomly selected subjects, including
the forecasted Uxi(t) after year 5. Note that the width of the forecasted credible
intervals is comparable to the theoretical results given in Corollary 1.
Table 3.1: PSA data: Posterior mean and quantiles of parameters for the SSVM-OU
and LMM.
Model Parameter Mean SD 2.5% 50% 97.5%
SSVM-OU σ2ε 0.044 0.004 0.037 0.044 0.053
σ2ξ 1.365 0.297 0.921 1.320 2.108
ρ 3.721 0.360 3.101 3.690 4.464
σ2ν 0.054 0.015 0.031 0.051 0.089
β0 -0.171 0.085 -0.335 -0.169 -0.004
β1 0.139 0.072 0.001 0.139 0.277
β2 0.242 0.095 0.060 0.237 0.438
β3 0.061 0.103 -0.157 0.064 0.269
LMM β20 0.061 0.066 -0.072 0.058 0.200
β21 0.116 0.056 0.008 0.117 0.225
β22 0.260 0.076 0.116 0.260 0.411
β23 0.046 0.078 -0.105 0.046 0.193
For comparison, we also analyze the PSA data using smoothing splines and a
parametric linear mixed model(LMM). The model fits are evaluated by the Deviance
Information Criterion(DIC, Speigelhalter et al., 2003). We further compare the fore-
casting ability of these three models on the validation data points. For the smoothing
spline approach, we obtain the estimates of Vxi(t) from the SSVM-W with Wiener
process as the prior for Vxi(t), where a{Vxi(t); xi,φi} = 0 and b{Vxi(t); xi,φi} = σξ
in equation (3.3). As mentioned in Section 3.2.1, the estimation of Vxi(t) from this
model, is equivalent to the estimation by a smoothing spline with a common smooth-
ing parameter λ =
σ2ξ
σ2ε
. The exact transition density in this SSVM-W, is given by
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Figure 3.2: Posterior means of Vxi(t) for each subject as gray dash lines and the
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Figure 3.3: Plots of training data points(◦), validation data points(+), posterior
means(—) and 95% credible intervals(gray shades) of Uxi(t) for six ran-
domly selected subjects.
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Wecker and Ansley (1983) as
[Uj, Vj | Uj−1, Vj−1, σξ] ∼ N2(mj, V j)
with
mj = [Uj−1 + Vj−1δj, Vj−1]T,














and will be used in the proposed MCMC algorithm. The forecasting of future obser-
vations is outlined in Section 3.3.3 for the SSVM-OU and SSVM-Ws. The paramet-
ric linear mixed model is specified similarly to the one given by Proust-Lima et al.
(2008a),
Yi(tij) = Uxi(tij) + εi(tij)







= (β00 + ν0i + β01XPi) + (β10 + ν1i + β11XPi + β12XTi)f1(tij)
+ (β20 + ν2i + β21XPi + β22XTi + β23XGi)f2(tij) + εi(tij), (3.12)








f1(t) = (1 + t)
−1.5 − 1 and f2(t) = t; the fixed effects βlmm = [β00, β01, β10, β11,
β12, β20, β21, β22, β23]
T ∼ N9(0, σ2β,lmmI9) a non-informative prior with large value of
σ2β,lmm; the random effects [ν0i, ν1i, ν2i]
T ∼ N3(0, Σν,lmm) with Σν,lmm a diagonal ma-








error εi(tij) ∼ N1(0, σ2ε,lmm). We further assume noninformative prior distributions
IG(A,B) with small values of A and B for σ2β,lmm, σ20ν,lmm, σ21ν,lmm, σ22ν,lmm and σ2ε,lmm,
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respectively. The MCMC algorithm for the linear mixed model (Ruppert et al., 2003,
Chap. 16) is conducted to draw the posterior samples with the same burn-in stage
and thinning scheme as for the MCMC algorithm for the SVC-OU model. Table 3.1
presents the posterior summary of the parameters β20, β21, β22, and β23, which are
involved in the long-term evolution U2xi(t) in equation (3.12). Note that for those
parameters in LMM, they are aimed to measure the association between the long
term stable level and the covariates of the interest, similar to the parameter β0, β1,β2,







of PSA at time t for the ith subject can be drawn from Y ri (t) ∼ N (U rxi(t), σ2 rε,lmm),





















22XT i + β
r
23XGi)f2(t).
Among these three models, the SSVM-OU fits the data best, with DIC equal to
71.809, which is less than 119.400 and 151.048, the DICs of the SSVM-W and the
linear mixed model, respectively. Next, we predict the 164 validation data points and
evaluate the posterior predictive ability of the three models. Table 3.2 presents the
magnitude of biases and mean squared errors(MSE) of the point forecasts, for which
we use the posterior means, and the coverage rate and averaged length of credible
intervals. For the 69 validation data points within 1 year distance from the last
training data points, the SSVM-OU performs best, in term of smaller Bias and MSE,
higher coverage rate and narrower interval length. For the later time validation data
points, the SSVM-W outperforms the other two in terms of bias and MSE. Overall
the coverage rates of the SSVM-OU intervals are closest to the nominal 95% level.
Note that the interval lengths from the SSVM-W are significantly wider than those
of SSVM-OU and LMM.
Besides evaluation of the point forecasts and the corresponding credible intervals,
we further use the probability integral transform (PIT, Dawid, 1984; Gneiting et al.,
2007) value to assess the predictive performance of the probabilistic forecasts. This
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forecast can be expressed as the posterior predictive cumulative distribution functions
(CDFs) Fij(Y ), where Y is the forecasted validation data point at time tij for the
ith subject and is assumed to be generated from the true unknown CDF Gij(Y ).
For the observed validation data point Yij, the PIT value pij = Fij(Yij) should has a
uniform distribution, if Fij(Y ) = Gij(Y ) for every i and j. We estimate Fij(t) by the
empirical CDF F̃ij(Y ), which is based on the Bayesian posterior forecasting draws
of the three models. The corresponding smoothed density plots of p̃ij are displayed
in Figure 3.4. The density of p̃ij for the SSVM-OU is left skewed, indicating the
forecasts are slightly under predicted, while the density for the linear mixed model is
right skewed and the forecasts are slightly over predicted. The density for the SSVM-
W is hump-shaped, implying the posterior predictive distribution is over dispersed
and the credible intervals are too wide on average. While none of the models gives
the ideal PIT plots, the plots of SSVM-OU and the LMM are reasonably close to a
uniform density.
Table 3.2: PSA data: Posterior forecasting of the validation data points.
Method Type Bias MSE Coverage Interval
Rate Length
SSVM-OU ≤ 1 year 0.225 0.085 1 1.404
> 1 year 0.537 0.489 0.905 2.378
All 0.406 0.319 0.945 1.968
SSVM-W ≤ 1 year 0.250 0.098 1 2.383
> 1 year 0.479 0.403 1 8.426
All 0.383 0.275 1 5.883
LMM ≤ 1 year 0.246 0.110 0.899 1.240
> 1 year 0.520 0.476 0.726 1.626
All 0.405 0.322 0.799 1.464
3.5 A Simulation Study
We carry out a simulation study to (i) assess the performance of the proposed
MCMC algorithm in estimating the model parameters and stable rates ν̄i(xi, β); (ii)
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Figure 3.4: PIT density plots for (a) tij ≤ 1 year, (b) tij > 1 year of SSVM-OU (—),
SSVM-W (−−−), LMM (· · ·)
compare the performance of the proposed SSVM-OU with the other two methods
for forecasting future observations. We generate 100 replicated datasets from the
SSVM-OU with the model parameter set close to those estimated from the analysis
of the PSA data. Each dataset include 20 subjects with 14 equidistant observations
and three validation data points per subject. The three validation data points are
0.08, 0.5 and 1 years after the last observation, respectively. To investigate the
influence of data augmentation on the estimation of the model parameters and stable
rates, we analyze the same dataset using the proposed MCMC algorithm without data
augmentation, and with one and three augmented data points between the consecutive
observed data points. The corresponding time interval between the adjacent data
points, either observed or augmented, decreases from 0.08 in the original datasets to
0.04 and 0.02 for the MCMC algorithm with one and three augmented data points
between neighboring observations.
Table 3.3 presents simulation results of model parameters and stable rates, as-
sessed by the magnitude of biases and mean squared errors of the posterior means
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and the coverage rate and average length of credible intervals. Those results indi-
cate that the data augmentation is critical to estimation of the parameter ρ. With
data augmentation, the bias of ρ reduces from 0.394 to 0.014 and the coverage rate
increases from 0.12 to 0.90. The data augmentation also moderately improves the
estimation of σ2ξ and σ
2
ν but has little effect on the estimation of other parameters.
Note that when we augment three data points between the adjacent observations,
the estimates of the parameters of interest, β1,β2 and β3 are virtually unbiased with
satisfactory coverage rates.
For the data simulated from the SSVM-OU, we further forecast the validation
data points by the SSVM-OU. Those data points are also predicted by the SSVM-W
and LMM (3.12). Table 3.4 compares the forecasting ability of posterior mean and
credible intervals for those three models, evaluated by Bias, MSE, coverage rate and
interval length. As we expected, the posterior means of the forecasting draws from
the SSVM-OU are smaller than those from the other models and the corresponding
interval lengths are narrower. Furthermore, it is of interest to study the robustness
or sensitivity of the forecasting ability of the SSVM-OU. We simulate another 100
datasets from the LMM specified as equation (3.12) in which the parameters are the
same as those estimated from the analysis of real PSA data. The simulation design,
including the number of subjects and observation and the position of validation data
points, are identical to those of the dataset generated from the SSVM-OU. The fore-
casting results are given in the second part of Table 3.4. We find that SSVM-OU
forecasts relatively well. Especially, when the time distance is 0.08, the forecasts of
SSVM-OU shows the same bias, smaller MSE, slightly lower coverage rate and ob-
viously shorter interval length, compared to the forecasts from the true LMM. The
forecasts from the SSVM-W are inferior to those by the SSVM-OU and the LMM.
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3.6 Discussion
This chapter considers modeling and inference for the rate function in longitudinal
studies with an application in the analysis of PSA biomarker profiles. For a given
subject, the rate of change is described by a rate function whose prior is assumed to
follow a Gaussian process conditional on the covariates. A key feature of this approach
is that the Gaussian stochastic process is specified by an SDE and is expected to be
centered on a pre-specified parametric function, while allowing significant deviation
from this functional expectation nonparametrically. We have focused on the case
where the rate function follows an OU process, motivated by analyzing PSA profiles.
The same modeling strategy and inference method should be widely useful in the
setting when we aim to model the rate function semiparametrically.
We propose an MCMC algorithm to estimate the posterior distribution of the
model parameters and rate functions. We apply the Euler approximation to facilitate
the sampling of the model parameters and use data augmentation of reduce the
approximation error. The accuracy of this approximation is supported by the results
from the simulation studies. We demonstrate that our proposed model has superior
forecasting ability, as least for the case when the rate function will evolve to some
stable level in the long term.
One can extend our model to discrete outcomes and to include the covariates in
equation (3.1). Moreover, a similar modeling and inference approach can be applied
to analyze the acceleration function, which is the third-order derivative of the mean
function. In addition, for simplicity, we assume the stable rates depend on the co-
variates through a parametric distribution, which could potentially be replaced by a
nonparametric distribution with a stick-breaking process as its prior. In future re-
search, it will also be interesting to consider alternative efficient algorithms to sample
the parameters and rate functions without relying on the Euler approximation.
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Table 3.3: Simulation results on the estimation of SSVM-OU parameters and stable
rates.
Data Parameter Truth Bias MSE Coverage Interval
Augmented ×10−2 Rate Length
0 σ2ε 0.05 0.001 0.003 0.93 0.019
σ2ξ 1.5 0.394 17.845 0.95 1.545
ρ 4 0.469 24.971 0.12 0.574
σ2ν 0.05 0.042 0.192 0.99 0.172
β0 -0.2 0.128 14.615 0.98 1.481
β1 0.15 0.021 5.747 0.95 0.914
β2 0.25 0.065 11.267 0.96 1.277




a+ νi 0.197 18.618 0.96 1.747
1 σ2ε 0.05 0.001 0.003 0.94 0.019
σ2ξ 1.5 0.357 17.930 0.96 1.585
ρ 4 0.173 7.302 0.80 0.687
σ2ν 0.05 0.030 0.111 1.00 0.142
β0 -0.2 0.127 15.221 0.94 1.366
β1 0.15 0.025 5.699 0.95 0.859
β2 0.25 0.065 11.671 0.94 1.168




a+ νi 0.202 19.237 0.95 1.675
3 σ2ε 0.05 0.001 0.003 0.93 0.019
σ2ξ 1.5 0.294 14.862 0.93 1.585
ρ 4 0.014 4.294 0.90 0.687
σ2ν 0.05 0.025 0.079 1.00 0.142
β0 -0.2 0.217 16.706 0.88 1.366
β1 0.15 0.022 4.808 0.96 0.859
β2 0.25 0.005 9.336 0.93 1.168




a+ νi 0.215 19.803 0.93 1.643
a XTi β = β0 + β1XPi + β2XT i + β3XGi
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Table 3.4: Simulation results on forecasting of three models
Simulation Fitted Year Bias MSE Coverage Interval
Model Model Distance Rate Length
SSVM-OU SSVM-OU 0.08 0.028 0.068 0.947 1.026
0.5 0.091 0.138 0.948 1.427
1 0.202 0.335 0.920 2.081
SSVM-W 0.08 0.040 0.142 0.993 1.986
0.5 0.240 1.491 1 14.954
1 0.595 5.533 1 39.040
LMM 0.08 0.283 0.342 0.920 2.028
0.5 1.456 2.444 0.235 2.174
1 3.494 12.679 0.008 2.500
LMM SSVM-OU 0.08 0.015 0.016 0.919 0.438
0.5 0.049 0.023 0.995 0.826
1 0.105 0.040 0.998 1.360
SSVM-W 0.08 0.062 0.038 0.988 0.952
0.5 0.386 0.699 1 7.073
1 0.759 2.654 1 18.446
LMM 0.08 0.014 0.055 0.957 0.948
0.5 0.012 0.055 0.957 0.959
1 0.014 0.057 0.956 0.975
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CHAPTER IV
Signal extraction and breakpoint identification for
array CGH data using robust state space model
4.1 Introduction
Almost all types of cancer share one common characteristic, genetic instability,
including DNA copy number variation(CNV). During cancer progression some genes
will lose one of the two copies or are completely deleted, while others may gain one
copy, or become amplified up to hundreds of copies. These chromosomal alterations
can lead to abnormal cell proliferation, DNA repair, senescence and apoptotic mech-
anisms and can provide a selective advantage for cells and result in cancer. Identifica-
tion of CNV not only enhances the understanding of oncogenesis but also facilitates
the treatment of cancer. For example, Trastuzumab is a monoclonal antibody in-
terfering with ERBB2 receptor and is used for the treatment of breast cancers with
amplified, and multiple copies of the ERBB2 gene (Vogel et al., 2002).
Array comparative genomic hybridization (CGH) is a technique that is used to
detect differences in DNA copy number (Solinas-Toldo et al., 1997; Pinkel et al.,
1998). The isolated DNA from tumor and the normal tissue from each patient are
labeled with different fluorescent dyes and then cohybridized to the microarray. The
log2 fluorescent intensity ratios are measured at different chromosomal positions to
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define each CGH profile. This CGH profile is supposed to be proportional to the
copy number ratio for tumor and normal cells across the chromosome. See Pinkel
and Albertson (2005) and Davies et al. (2005) for detail reviews. Array CGH data
exhibit three challenging characteristics. First, the data displays abrupt changes at
the positions where DNA copy number is possibly altered. Second, the data usu-
ally contain biological variations and experimental errors, which hinder the accurate
identification of breakpoints where copy number changes. Biological variations refer
to heterogeneity of copy number within tumor cells and experimental errors include
contamination of the tumor cells with normal cells, measurement errors and errors
caused by processing tissue samples. Third, the data are spatially dependent. That
is, neighboring genes are more likely to share the same copy number than remote
ones. The primary aim of array CGH data analysis is to estimate the CGH profiles
and to identify breakpoints from available noisy observations.
A number of statistical methods have been proposed for array CGH data analysis.
Most of the methods postulate that the observed log2 intensity ratio Y (tj) is governed
by the following model,
Y (tj) = U(tj) + ε(tj), j = 1, 2, . . . , J (4.1)
where signal U(tj) is the unobserved log2 intensity ratio at jth probe, ε(tj) is the
noise or measurement error and tj denotes the physical position of jth probe on a
chromosome. Different assumptions and interpretations of U(tj) and ε(tj) lead to
various estimation approaches, which may be categorized into three types. The first
type is based on the segmentation method. It assumes that the CGH profile U(t),
is piecewise constant, i.e. U(tj) =
∑M
m=1 UmI[tj ∈ Tm], where Tm is segment m
with level Um and I(·) is the indicator function. Also ε(tj) follows independent and
identically distributed (i.i.d.) N (0, σ2ε). To detect breakpoints that enable us to
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classify chromosome into blocks, Olshen et al. (2004) and Venkatraman and Olshen
(2007) proposed the method of circular binary segmentation(CBS); Hupe et al. (2004)
developed the adaptive weighted smoothing procedure; and Erdman and Emerson
(2008) implemented a Bayesian change point model.The second type is the method of
hidden Markov models (HMM), which restricts U(t) to take a finite number of values
and uses a Markov chain to model probabilities: Pr(U(tj+1) = Um′ | U(tj) = Um),
Um, Um′ ∈ U , with state space U = {Um; m = 1, 2, . . . , M}. Note that M is a
prespecified number of states. The HMM method was first applied to array CGH data
analysis by Fridlyand et al. (2004). Shah et al. (2006) modified the HMM method
to achieve robustness against outliers. A continuous-index HMM was developed by
Stjernqvist et al. (2007). Guha et al. (2008) derived a Bayesian approach to the HMM
with objective decision rules. A segmental maximum posteriori approach(SMAP) by
Andersson et al. (2008) has incorporated both genomic distance and overlap between
clones into the HMM. Finally, the third type is built upon penalization methods,
which essentially relax the piecewise constant assumption by imposing a roughness
penalty on CGH profile U(t). In a penalization method, we consider minimizing an
objective function of the form Q = Qgf + Qsp, where the first term Qgf measures the
goodness of fit for profile U(t) to the observed process Y (t) at observed probes t′js,
and the second term Qsp regularizes the smoothness of U(t). Various forms of Qgf
and Qsp have been proposed in the literature, including quantile smoothing (Eilers
and De Menezes, 2005), LASSO (Huang et al., 2005), fused quantile regression(Li
and Zhu, 2007) and fused LASSO (FLASSO) by Tibshirani and Wang (2008).
Besides the three types of methods, there are other approaches; for example, clus-
tering algorithm (Wang et al., 2005; Liu et al., 2006), wavelet transform (Hsu et al.,
2005) and ridge regression (van de Wiel et al., 2009), among many others. Compre-
hensive comparisons among some of aforementioned methods were given by Lai et al.
(2005) and Willenbrock and Fridlyand (2005). Some of the methods only estimate
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the profiles but do not directly call the breakpoints. Further, most methods do not
control the false positive rate for breakpoint identification, and their performances
are significantly effected by the experimental errors, such as outliers.
In this paper, we propose a new method based on robust state space models
for array CGH data to estimate the CGH profile and to identify breakpoints under
controlled false positive rates. In addition, this new method has a number of desirable
properties: (1) it is robust against outliers; (2) it incorporates physical distance
between probes into CNV identification; (3) it enables us to quantify estimation
uncertainties of signals via posterior credible intervals; (4) all the parameters are
estimated as part of the MCMC algorithm and thus are highly data-adaptive; (5) the
computational efficiency of the MCMC algorithm for profile estimation is proportional
to the number of probes, which helps the computation speed for high-throughput
array CGH data analysis.
The rest of the paper is organized as follows. In Section 2, we first present the
robust state space model, then describe an MCMC algorithm to draw samples of both
profiles and parameters, and also outline a novel procedure of calling the breakpoints
and outliers using MCMC samples. In Section 3, the proposed model and method
are applied to both simulated and real datasets for illustration, where we compare
our new method to three popular existing methods. We finally give conclusions and
discussion in Section 4.
4.2 Methods
4.2.1 Model
For the ease of exposition, we denote Yj = Y (tj), Uj = U(tj) and εj = ε(tj). The
proposed robust state space model(RSSM) comprises two equations: an observation
equation and a state equation. The observation equation is given in equation (4.1),
61
where measurement error εj is assumed to be i.i.d and follow t-distribution, Tυε , with
degree of freedom(d.f.) υε. Note that t-distribution is a scale-mixture of normal
distribution and gamma distribution. Thus, we rewrite εj ∼ N (0, σ2ε,j) a normal dis-
tribution with mean 0 and variance σ2ε,j, and let σ
−2
ε,j = λε,jτε and λε,j ∼ G(υε/2, υε/2)
a gamma distribution with shape parameter υε/2 and rate parameter υε/2. The non-
informative priors are specified as υε ∼ G(10−3, 10−3)I(2, 10) and τε ∼ G(10−3, 10−3)
throughout the paper.
We regard the signal U(tj) as a continuous quantity which measures the log2 of
average copy number of heterogeneous tumor cells versus homogeneous normal cells.
The state equation is:
Uj+1 = Uj + ξj, (4.2)
where the evolution error or signal difference ξj follows an i.i.d t-distribution with d.f
υξ. Similar to the specification of εj, we let ξj ∼ N (0, σ2ξ,jδj), δj = tj+1 − tj, σ−2ξ,j =
λξ,jτξ and λξ,j ∼ G(υξ/2, υξ/2), with the priors υξ ∼ G(10−3, 10−3)I(0.01, 2) and
τξ ∼ G(10−3, 10−3). As a result, εj ∼ Tυε(0, τ−1ε ) and ξj ∼ Tυξ(0, δjτ−1ξ ) marginally.
Unlike other robust state space models (West, 1984; Fahrmeir and Künstler, 1999),
our model incorporates the physical distance δj between two probes to address the
feature that the farther two probes are apart, the larger the signal difference ξj is
likely to be. Note that degree of freedom υξ is limited below 2. In this way, we hope
that the distribution Tυξ can accommodate extremely large values of signal difference
probably caused by breakpoints. A similar strategy was suggest by Kitagawa (1987),
where differences of signals are modeled by a distribution in the Pearson system with
no finite second moments. As shown in his paper, the Pearson system distribution
facilitates the detection of mean structure changes.
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4.2.2 Signal extraction by MCMC
With the model formulation given in Section 2.1, we now outline an MCMC
algorithm to sample from the posterior distribution for signals U = [U1, U2, . . . , UJ ]
>,
parameters φo = [λε,j, υε, τε] and φs = [λξ,j, υξ, τξ] for j = 1, 2, . . . , J , given the data
Y = [Y1, Y2, . . . , YJ ].
• Given Y , φo and φs, update the U by the simulation smoother (Durbin and
Koopman, 2002a), a multi-state Gibbs sampler which very efficiently draws
samples from the posterior distribution of signals U .
• Given Y and U , update φo according to the following steps:




[υε |· ] =
∏J
j=1 G(λεj | υε2 , υε2 )G(υε | 10−3, 10−3)I(2, 10), by Adaptive Metropolis
Rejection Sampling (ARMS; Gilks et al., 1995);






• Given U , update φs through the following steps:







[υξ |· ] =
∏J
j=1 G(λξj | υξ2 ,
υξ
2
)G(υξ | 10−3, 10−3)I(0.01, 2), by the ARMS;






According to the definition of errors εj = Yj − Uj and ξj = Uj+1 − Uj, we obtain
the posterior draws of the errors ε = [ε1, ε2, . . . , εJ ]
> and the signal differences ξ =
[ξ2, ξ3, . . . , ξJ ]
>. Samples of ε and ξ are essential to identify outliers and breakpoints
through a novel backward selection procedure detailed in Section 2.3 below.
4.2.3 Breakpoints and outliers calling
Breakpoints are called by our backward selection procedure outlined in Algorithm
1 given in the Appendix D. The input to the algorithm is the posterior draws of
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signal differences ξ, in an m×n matrix, with m denoting the number of draws and n
equal to the number of probes minus one, as well as an input of a threshold qα. The
specification of qα is discussed in detail below. At line 6 in Algorithm 1, we calculate
P̃j, which is an estimate of the posterior probability P [|ξj| > |ξ−j| | Y ]. This is the
probability of the absolute value of signal difference at position j is larger than those
at any other positions, given the data. The quantity P [|ξj| > |ξ−j| | Y ] represents
the area under the ROC curve or AUC (Pepe, 2004, Ch.4). It is known that AUC
measures the separation between the posterior distribution of |ξj| and that of the
remaining |ξ−j|, namely all |ξi| with i 6= j. Under the null hypothesis that probe j
is not a breakpoint, we expect P̃j to be near 0.5. The decision of rejection of the
null hypothesis will be based on the comparison of P̃j with the threshold qα. In the
first iteration of procedure, several P̃ ′js may be larger than qα; we take the largest one
and call it a breakpoint. This called position will be excluded from the subsequent
iterations. We repeat his calling procedure for the remaining ξj until none of the
remaining P̃j is above the threshold qα or all n − 1 breakpoints are selected. The
output of the algorithm is a list of identified breakpoints. Likewise, we utilize this
backward selection procedure to call outliers, based on the posterior draws of errors
ε.
In the above backward selection procedure for the calling of breakpoints, the qα is
determined such that under the null hypothesis that probe i is not a breakpoint, it will
be chosen with probability α(i.e. α is false positive rate). When a normal reference
array is available, we can measure log2 intensity ratio of normal versus normal tissue.
Fitting the proposed state space model to the normal reference array, we obtain
the posterior draws of signal differences ξo, where we can obtain P̃ o
′
j s according to
Algorithm 1. These P̃ oj , j = 1, 2, . . . , J
o, can be regarded as a random sample from
a distribution under the null hypothesis. Then, the qα is obtained as the (1 − α)
quantile of all P̃ o′j s. This quantile qα implies that under the null hypothesis, the rate
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of false positive is α. In some real experiments, normal reference arrays however
may not be available. In this case, we can generate a pseudo normal reference array
Y o = [Y o1 , Y
o
2 , . . . , Y
o
Jo ] by sampling with replacement from the data Y . In this case,
if some Y ′j s in the aberration region are sampled, they will be dispersed and scattered
randomly within the set Y o. Thus, they appear most likely as outliers rather than a
contiguous pattern of changes. Since the proposed state space model is robust against
outliers, the qα under the null hypothesis can be reasonably determined. Given the
pseudo normal array, the steps to obtain the qα are the same as those given in the
scenario of the normal reference array being available. Note that for calling the
outliers, the qα can only been obtained when normal reference array is available.




We first evaluate our proposed method and compare it with three other popular
methods, FLASSO, CBS and SMAP, using well known artificial chromosomes simu-
lated by Lai et al. (2005)(multi-subject functional data for download at
http://www.chip.org/~ppark/ Supplements/Bioinformatics05b.html. Lai et al.’s
data consist of 100 chromosomes, each with length 100. In the center of each chromo-
some is added an aberration of copy number gain, which has one of the four different
width (5,10,20 and 40). The signal-to-noise ratio(SNR) is 1, and the noise follows a
normal distribution with standard deviation 0.25.
We use the Receiver Operating Characteristic(ROC) curve to compare the perfor-
mance of the four methods in each width case. To obtain ROC curves, we compare
the estimated signal Ûj at each location with a cutoff varying from the minimum to
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the maximum of Y , and regard the location i where Ûi is above the cutoff as the
detected aberration region. The true positive rate(TPR) is defined as the proportion
of the true aberration region detected as an aberration region, while the false positive
rate(FPR) is defined as the proportion of the normal region declared as an aberration
region. The TPRs and FPRs are plotted as ROC curves in Figure 4.1. For the Lai et
al.’s data, the plots at the first row in Figure 4.1 indicate that our approach performs
clearly better than CBS and SMAP methods, in terms of higher TPR and lower FPR,
not as well as FLASSO for the narrow regions but comparably to FLASSO for the
wide aberrations(20 and 40).
The simulated data in Lai et al. (2005) is idealized, and does not contain any
of the complex features that occur in real data. Outliers are commonly seen in real
datasets for various reasons, including single probe amplification/deletion or experi-
mental errors. To investigate the effect of outliers, in Lai et al.’s simulated dataset,
we add five percent of outliers in each chromosome at randomly selected positions
with magnitudes uniformly distributed over interval (3, 6). The ROC curves given
at the second row in Figure 4.1 clearly show the advantage of the proposed method.
Comparing to the corresponding cases in the first row, the ROC curves of FLASSO,
CBS and SMAP are considerably closer to the diagonal line, demonstrating a signifi-
cant loss of prediction power for the detection of CNVs. In contrast, the ROC curves
of the proposed approach are affected very little, indicating clearly that our method
is robust to outliers.
Another feature of the real data is the possibility of more than one region of
aberration with different magnitudes. To evaluate the performance of the methods,
we explore cases when two aberration regions are present in the simulated chromosome
simultaneously. For each Lai et al.’s simulated chromosome, a randomly selected
normal region of width five is replaced by an aberration block with SNR 4. Based




















































Figure 4.1: ROC curves of four methods at SNR 1. — Our model,−−− FLASSO,
− ·− CBS, · · · SMAP.
outperforms the three other approaches.
An important task in array CGH analysis is to correctly identify breakpoints. We
investigate the number of breakpoints identified by the four methods for each chro-
mosome in the above simulated data. In addition, we simulate normal chromosomes
without any aberration regions. For these we generate 100 normal chromosomes, each
with 100 probes simulated from N (0, 0.252). In addition, another 100 chromosomes
are generated by adding outliers to the 100 normal chromosomes, in the same way
described above. For FLASSO, CBS and SMAP, a breakpoint is defined as a position
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j, if the difference is non-zero, that is, ∆Ûj = Ûj+1 − Ûj 6= 0. For the proposed
method, a breakpoint is called by the backward selection procedure as described in
Algorithm 1. To determine the qα, we simulate a normal reference array with each
probe as N (0, 0.252) with length Jo = 1000 and generate the pseudo normal reference
arrays with length Jo = 1000 through sampling with replacement from the artificial
chromosomes. The false positive rate α is set at 0.001, which means that for ev-
ery 1000 probes in the normal reference array, one probe is expected to be falsely
called as a breakpoint. Figure 4.2 shows the side-by-side boxplots of the number of
breakpoints identified by each of four method respectively, where the qα is determined
with simulated normal reference arrays and pseudo normal reference arrays, respec-
tively, for RSSM0 and RSSM1 corresponding to the first two boxplots in each panel.
From a comparison of these boxplots, it is clear that the number of breakpoints is
over-estimated substantially by FLASSO in all the three scenarios although the mag-
nitude of the signal difference at some of these breakpoints may by quite small. The
true number of breakpoints, on average, is more likely to be correctly achieved by
the proposed method, in scenario of two pieces of aberration regions or in the cases
where the aberration widths are as wide as 20 and 40. For the normal chromosomes
with or without outliers, both CBS and our method correctly conclude that there are
no breakpoints, while FLASSO identifies a few number of false breakpoints. Note
that our method identifies a total of 6 and 13 breakpoints for 10,000 probes in 100
normal chromosomes by using, respectively, simulated and pseudo normal reference
arrays. These number of false discoveries numbers are close to the expected number
10, given the false positive rate 0.001. We also notice that the numbers of breakpoints
identified in the simulated and pseudo normal reference arrays are very close to each
other, which validates the utility of pseudo normal reference arrays when the normal
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Figure 4.2: Breakpoints identification using simulated and pseudo normal reference
arrays. The horizontal reference lines indicate the true number of break-
points. The simulated normal reference array is labeled by RSSM0, while
RSSM1 utilizes pseudo normal reference arrays based on resampling the
observed data. The panel on bottom left is the replicate of the one on
top left.
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4.3.2 Glioblastoma Multiforme(GBM) data
GBM data by Bredel et al. (2005) include 26 samples representing primary GBMs,
the most malignant type of brain tumor. In sample GBM31, a large region of loss
is demonstrated on chromosome 13, which is also observed by Koschny et al. (2002)
in a meta-analysis of 509 cases. Besides losses, the GBM data also contain a num-
ber of amplifications, one of which is shown on chromosome 7 in sample GBM29.
Lai et al. (2005) compared the performance of various methods based on these two
chromosomes 13 and 7 with challenging features. They represent wider, low level
region of loss, and narrower, high level region of amplification, respectively. To assess
our proposed method, we re-analyze these two chromosomes using our method. The
analysis is based on 1000 MCMC draws from a single chain of 75, 000 iterations with
25, 000 burn-in period and every 50th being recorded. As shown in Figure 4.3 , our
method successfully detects both the loss region and amplification region as well as
some outliers. Both breakpoints and outliers are called using the proposed backward
selection procedure. The threshold for breakpoints is obtained through the pseudo
normal reference arrays with qξ0.001 = 0.911 for chomosome 7 and q
ξ
0.001 = 0.882 for
chomosome 13. The threshold for outliers is chosen as qε = 0.98. The panels in
Figure 4.3 also illustrate posterior means and 95% credible intervals for signal Uj,
error εj and signal differences ξj across the chromosomes. At a given position, the
wider interval indicates higher uncertainty. Note that 95% credible intervals of sig-
nal difference illustrate the corresponding posterior distributions. The further the
credible interval departs from the others along with the narrower width, the stronger
it indicates the corresponding position is a breakpoint. We also analyze the GBM
data using the methods of FLASSO, CBS and SMAP. As Figure 4.4 shown, all three
methods can identify the two aberration regions, except SMAP method that fails to
detect any aberration region for chromosome 13.
Table 4.1 lists the number of breakpoints identified by each of the four methods.
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(b) Chromosome 13 in GBM31
Figure 4.3: GBM panel plots for the posterior distributions of measurement error,
signal, and signal difference by state space model. In the top and bottom
panels, the • denotes the posterior mean and | stands for the 95% credible
intervals. In the middle panel, gray • is the data point and —is posterior
mean and 95% credible intervals are the shaded areas. vdenotes the
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Figure 4.4: Panel plots of signal(—) estimated for GBM data by FLASSO, CBS and
SMAP, where gray • denotes the data point.
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Our method and CBS reach the same numbers on both chromosomes, which are much
less than the those found by FLASSO.
4.3.3 Breast tumor data
Fridlyand et al. (2006) considered array CGH data from across 2464 genomic clones
in 62 sporadic ductal invasive breast tumors and 5 BRCA1 mutant tumors. We apply
our method as well as other three methods to analyze four chromosomes(8,11,17 and
20) of tumor “S1539”, in which there are a number of low level gains and losses
as well as high level amplifications. The results of our method are based on 1000
MCMC draws from a single chain of 75, 000 iterations with 25, 000 burn-in period
and every 50th being recorded. The backward selection procedure has been applied
to identify a number of breakpoints and outliers/amplifications. The qε is specified
as 0.98, and qξ0.001 is determined using the pseudo normal reference arrays, resulting
in values of 0.795, 0.789, 0.808 and 0.807 for chromosome 8,11,17 and 20 respectively.
Figure 4.5 displays the posterior means and 95% credible intervals of signal Uj, error
εj and signal differences ξj across the chromosomes, as well as a number of called
outliers and breakpoints. These breakpoints define the edges of aberration regions
which include several well-known oncogenes, that play key roles in the pathogenesis of
breast tumor. The detected regions cover gene FGFR I between 36.4Mb and 39.7Mb
on chromosome 8, gene CCND I between 68.5Mb and 77.0Mb on chromosome 11, and
gene ZNF217 between 44.4Mb and 62.7Mb on chromosome 20. Gene ERBB2 between
34.1Mb and 38.7Mb on chromosome 17 is a well known gene that can be amplified in
Table 4.1: The number of breakpoints identified in GBM and Breast Tumor data
GBM data Breast Tumor data
CH7 CH13 CH8 CH11 CH17 CH20
RSSM(ours) 6 1 9 5 3 4
FLASSO 15 15 30 19 29 12
CBS 6 1 3 6 0 2
SMAP 4 0 6 11 8 9
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breast cancer. There are very few probes close to ERBB2, and the method detected
a probe as an outlier in this region.
We also analyze the same breast tumor data by FLASSO, CBS and SMAP meth-
ods. The results are shown in Figure 4.6. We can see that the SMAP method
appears to be very sensitive to outliers(e.g. in chromosome 11) and local features(e.g.
in chromosome 20), which has obscured the estimate of the global trend. The CBS
method failed to capture the single probe amplification in the chromosome 17 and
the weak gain in chromosome 20. The FLASSO method is also sensitive to outliers,
e.g. at the beginning of chromosome 8 and in the middle of chromosome 11. The
number of breakpoints identified by each of the methods is summarized in Table 4.1.
FLASSO identifies a large number of breakpoints, our method identifies slightly more
breakpoints than CBS and slightly fewer than SMAP.
4.4 Discussion
In this paper, we have proposed a powerful new method based on a robust state
space model to detect CNVs from array CGH data. A key feature of the proposed
method is the use of heavy tail t-distributions, which facilitates the robustness in
the calling of breakpoints and outliers. Through an MCMC algorithm, our approach
presents an appealing method for CGH profile estimation and detection of break-
points. Our method is based on a probability model that gives not only point estima-
tion, but also uncertainty intervals for the signal, signal difference and measurement
error magnitudes, as illustrated in Figure 4.3 and 4.5. Such displays are very useful
for visualizing the data and the degree of confidence in any conclusion. We devel-
oped a novel backward selection procedure to effectively utilize the MCMC samples
in the identification of breakpoints and outliers/amplifications. Importantly, we con-
trol the false positive rate of feature detection at a prespecified level by using real or









































































































































































































































































Figure 4.5: Breast tumor panel plots for the posterior distributions of measurement
error, signal, and signal difference by state space model. In the top and
bottom panels, the • denotes the posterior mean and | stands for the
95% credible intervals. In the middle panel, gray • is the data point
and —is posterior mean and 95% credible intervals are the shaded areas.
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Figure 4.6: Panel plots of signal(—) estimated for breast tumor data by FLASSO,
CBS and SMAP, where gray • denotes the data point.
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our approach has demonstrated superior detection power for aberration regions and
breakpoints, and outperforms other existing methods in most of cases, especially for
noisy data with outliers.
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CHAPTER V
Conclusions and Future Work
5.1 Conclusions
In this thesis, we propose the stochastic dynamic model(SDM) for functional data
analysis. Distinct from the classic smoothing and kernel methods, we treat the un-
known function as a realization of a stochastic process, whose distribution is deter-
mined by a stochastic different equation(SDE). In this way, the proposed model is
very flexible to address various research questions with different applications. Chap-
ter II introduce a special case of SDM, the stochastic velocity and acceleration models
to analyze the prostate specific antigen(PSA) profile for time series functional data.
Chapter III extend the stochastic velocity model for the multi-subject functional data,
where we not only analyze multiple profiles simultaneously, but also consider the effect
of covariates on the shape of profiles. Chapter IV considers the time-varying stochas-
tic position model, where the diffusion term in the SDE varies over time. Hence,
the model can approximate the breakpoints in the function and is applied to array
comparative genomic hybridization(CGH) data.
To estimate the parameters and functions, we apply Euler approximation to dis-
cretize the SDE and use data augmentation to reduce the approximation errors.
Markov Chain Monte Carlo(MCMC) algorithms are developed for each model, where
the simulation smoother can be used to sample the values of the functions simulta-
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neously in blocks instead of one value at a time, and thus the convergence of the
algorithm is fast. From the MCMC output, the forecasting of future observations can
also be easily obtained.
5.2 Future Work
For future work, we will propose another new model, namely a stochastic func-
tional mixed model(SFMM) for multi-subject functional data. We also plan to gen-
eralize the Wiener process W (t) to the Lévy Process Z(t).
5.2.1 Model
First, to analyze the data for one subject in a longitudinal study, i.e. time series
functional data, we modify the SVM-W proposed in the chapter II by generalizing a
zero drift function with a Weiner process. The resulting model, tentatively named as
adaptive SVM-W, is more flexible to study the drift function nonparametrically and
it is easily extended to the longitudinal study. The model is defined by a hierarchical
structure:
Y (t) = µ(t) + ε(t), t ∈ To = {t : t1, t2, . . . , tJ}
dµ(t) = ν(t)dt, t ∈ Ts = {t : t0 ≤ t ≤ tJ}




where W ξ(t) and W ζ(t) are two independent standard Wiener processes and ε(t) ∼
N (0, σ2ε). In this model, the drift term will be data driven, which leads to potentially
better model fitting and interpretation.
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After some stochastic integrations, we get,













where µ(t0), ν(t0) and α(t0) are the parameters at initial time t0, which are assumed
[µ(t0), ν(t0), α(t0)]
> ∼ N3(0, σ20I3). In addition, we can show that the estimation




[y(tj)− µ(tj)]2 + λξ
tJ∫
t0










are two smoothing parameters, which control the smooth-
ness of µ(t) and α(t), respectively.
Second, to analyze multi-subject functional data, we extend the above hierarchical
model as follows. As an example of including covariates, we assume subjects are
divided into k groups. For subject i in group k, we impose a stochastic functional
mixed model(SFMM):
Yi,k(t) = µi,k(t) + εi,k(t), t ∈ To = {t : t1, t2, . . . , tJ} (5.1)
dµi,k(t) = νi,k(t)dt, t ∈ Ts = {t : t0 ≤ t ≤ tJ} (5.2)






Let fi,k(t) = µi,k(t0)+νi,k(t0)t+σξ
∫ t
s=t0









W ζk (x)dxds. Assume [µi,k(t0), νi,k(t0), αk(t0)]
> ∼ N3(0, σ20I3).
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Then, µi,k(t) can be rewritten as
µi,k(t) = gk(t) + fi,k(t),
where gk(t) represents the kth group population-average curve and fi,k(t) as the
subject-specific curve deviation from the population-average profile. Note that SFMM
can be regarded as an extension of the random intercept and random slope mixed
effects model, with now additional stochastic terms derived from the two Wiener
processes. We will investigate whether the SFMM includes other existing models as
special cases.
For estimation and inference, we will first develop Bayesian methods using MCMC.
Then, we will establish subject-specific forecasting. We will apply SFMM to analyze
simulated and real world data. Results will be compared to those obtained by existing
models. We will consider adding covariates into equations (5.1) to (5.4), besides the
group stratification.
5.3 Some preliminary results
We present two examples to demonstrate the potential of the two proposed models.
The adaptive SVM-W is fit to two datasets using MCMC.
The first example is the analysis of melanoma incidence data reported by Houghton
et al. (1980). 37 incidences of malignant melanomas were recorded yearly for males
in Connecticut between 1936 and 1972, shown in Figure 5.1. The incidences display
an increasing trend plus some periodic pattern, which may be associated with sun
radiation fluctuation due to sunspot activity. We fit both the SVM-W described in
the chapter II and the adaptive SVM-W in this chapter. The results are shown in
Figure 5.1. It can be seen that the adaptive SVM-W fit the data better, which cap-
ture both the linear trend and periodic pattern. This conclusion is supported by a
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smaller deviance information criteria(DIC). Hence, adaptive SVM-W is more flexible
to capture the various pattern of function without subject matter prior knowledge.
The second example is analysis of data concerned with protein contents in milk
samples taken from Diggle (1990). Protein contents of milk samples were repeat-
edly measured for 79 cows weekly up to week 19. The cows were assigned to three
treatment groups: diet 1(barley), diet 2(mixed, barley and lupins) and diet 3(lupins).
We carry out a two-stage analysis for SFMM. We first fit the adaptive SVM-W for
each cow and estimate subject-specific curves. The MCMC samples from the same
group are then averaged to estimate the group-average curves. The estimated pro-
files for each cow in diet 1 group are given in Figure 5.2. It can be seen that the
subject-specific curves vary from each other significantly. The group-average profiles
are shown in Figure 5.3. Three groups have separable group-average curves. These
two figures display subject-specific curve deviations and group-average curves that
could be captured by the proposed SFMM.
82


















(a) By SVM-W, DIC=25.95


















(b) By adaptive SVM-W, DIC=15.79
Figure 5.1: Melanoma incidences from year 1936 to 1972. Plots of data points(•),
posterior means(—) and 95% credible intervals(shades) for the SVM-W






















































































Figure 5.2: Protein contents in milk samples: Plots of posterior means(—) and 95%
credible intervals(shades) for each cows in diet group 1.
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Efficient MCMC scheme for SVM-OU
Here we outline an efficient MCMC scheme for the SVM-OU. The efficiency takes
root in the Markov property of the latent process and is achieved by the simulation
smoother.
When V (t) follows an OU process, the Euler approximation gives the following
discretized forms:
Ui = Ui−1 + Vi−1δi,
Vi = Vi−1 − ρVi−1δi + ρν̄δi + ξi
= (1− ρδi)Vi−1 + ρδiν̄ + ξi, ti ∈ Tao,
where Tao := {ti : i = 1, 2, . . . , J +
∑J−1
j=0 Mj} and ξi ∼ N (0, σ2ξδi).
With the observation equation (2.1), we rewrite the above discretized forms as a
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standard discrete-discrete state space model:







































+ ωi = Giθi−1 + ωi, (A.2)
where εi































Given σ2ε , φs, yo and ya, we apply the simulation smoother (Durbin and Koopman,
2002b) to update the latent state θi.
Given latent state θi, yo and ya, the above state space model can be reformulated
as two linear regression models in which parameters σ2ε and φs will be sampled by
the standard Gibbs sampling methods.




















i.i.d∼ N (0, σ2ξ ) and prior [β0, β1]> ∼ N2(0, σ2βI2) with σ2β = 106 and β1 ∈ R−;
the prior σ2ε ∼ IG(a, b) and σ2ξ ∼ IG(a, b) with a = b = 0.001. Finally, given both θi
and σ2ε , the element of ya are sampled from φ(yi | Ui, σ2ε).
When V (t) follows a Wiener process, the above MCMC scheme can modified to












 with little effort. The
MCMC scheme of the SAM-W and SAM-OU can be formulated in the same way.
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APPENDIX B
Link to linear mixed model for SVM-W
The SVM with the Wiener process V (t) and approximated transition density can
be written as a linear mixed model(LMM). It will be identical or similar to the linear
spline model with the truncated line function basis, depending on whether or not
data are equally spaced.
When a{V (t),φs} = 0 and b{V (t),φs} = σξ, we discretize (2.2) and (2.3) for
m = 2 by Euler approximation without data augmentation, and get,
∆U(tj) = U(tj)− U(tj−1) = V (tj−1)δj,
∆V (tj) = V (tj)− V (tj−1) = σξηj,
where δj = tj − tj−1, ηj = W (tj)−W (tj−1) ∼ N (0, δj), j = 1, 2, . . . , J with t0 = 0. It
is easy to see that








where f(x)+ is the positive part of function f(x). Plugging U(tj) into equation (2.1),
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we obtain
Yj = U(tj) + εj
= U(t0) + V (t0)tj + σξ
J−1∑
k=1
(tj − tk)+ηk + εj
= x>j θ0 + z
>
j γ + εj,
where xj = [1, tj]





δ2(tj − t2), . . . ,
√






, . . . , ηJ−1√
δJ−1
]> ∼ NJ−1(0, σ2ξIJ−1).Thus,
Y = Xθ0 + Zγ + ε,
where X = [x1 | x2 | · · · | xJ ]> and Z = [z1 | z2 | · · · | zJ ]>. This is a linear mixed




ε . If δj = δj′ for
any pair of j and j′, then this LMM is sometimes called a linear spline model with
truncated line function basis (Ruppert et al., 2003).
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APPENDIX C
Proof of theorem 1
C1: The solution for OU SDE:
Let Z(t) = V (t)− ν̄. We have
dZ(t) = dV (t) = −ρZ(t)dt + σξdW (t).
Due the fact that for any two continuous functions g(t) and f(t),
t2∫
t1













Thus, for t1 = tj−1, t2 = tj, g(s) = Z(s) and f(s) = exp(ρs),







= Z(tj−1) exp(ρtj−1) +
tj∫
tj−1
exp(ρs) {ρZ(s)ds + dZ(s)}




It follows that with δj = tj − tj−1, then we get
Z(tj) = Z(tj−1) exp(−ρδj) + σξζj ,
where ζj = exp(−ρtj)
∫ tj
tj−1
exp(ρs)dW (s). It is easy to show that E(ζj) = 0, and























V (tj) = ν̄ + {V (tj−1)− ν̄} exp(−ρδj) + σξζj, (C.1)
93
with E {V (tj) | U(tj−1), V (tj−1), ν̄, ρ, σξ} and V ar {V (tj) | U(tj−1), V (tj−1), ν̄, ρ, σξ)}
equal to those given in Theorem 1.
C2: The solution for IOU SDE
From equation (C.1), We have




= U(tj−1) + ν̄δj +
tj∫
tj−1












































[1− exp{−ρ(tj − s)}] dW (s).
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Moreover, we can show that E[ξj] = 0, and





















[1− exp{−ρ(tj − s1)}dW (s1)
tj∫
tj−1

















{1− 2 exp(−ρδj) + exp(−2ρδj)}.
Finally, it is trivial to show that E{U(tj) | U(tj−1), V (tj−1), ν̄, ρ, σξ}, V ar{U(tj) |
U(tj−1), V (tj−1), ν̄, ρ, σξ} and Cov{U(tj), V (tj) | U(tj−1), V (tj−1), ν̄, ρ, σξ} are those
given in Theorem 1.
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APPENDIX D
Backward selection procedure for the breakpoints
Input: Mm×n, qα
1: J ← ∅ and flag ← true
2: repeat
3: for j = 1 to n and j /∈ J do
4: V−j ← m samples without replacement from columns I of M , I = {i : i 6=
j and i /∈ J }







k′=1 I(|Vj[k]| > |V−j[k′]|)
7: end for
8: if ∃j ∈ {1, 2, . . . , n} and j /∈ J : P̃j > qα then
9: j ← j : P̃j > P̃j′ all j′ 6= j
10: J ← J ∪ {j}
11: else
12: flag ← false
13: end if
14: until flag = false or number of elements in J = n− 1
15: if number of elements in J = n− 1 then
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